Guido Ferrari | Scholars@Duke

Guido Ferrari
Associate Professor of Surgery

The activities of the Ferrari Laboratory are based on both independent basic research and immune monitoring studies. The research revolves around three main areas of interest: class I-mediated cytotoxic CD8+ T cell responses, antibody-dependent cellular cytotoxicity (ADCC), gene expression in NK and T cellular subsets upon infection with HIV-1. With continuous funding over the last 11 years from the NIH and Bill & Melinda Gates Foundation along with many other productive collaborations within and outside of Duke, the Ferrari Lab has expanded its focus of research to include the ontogeny of HIV-1 specific immune responses that work by eliminating HIV-1 infected cells and how these can be induced by AIDS vaccine candidates.

Office Hours

Monday-Friday 08:00-18:00
Saturday and Sunday upon request

Current Appointments & Affiliations

Associate Professor of Surgery, Surgery, Surgical Sciences, Surgery 2013
Associate Research Professor in Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2014
Member of the Duke Human Vaccine Institute, Duke Human Vaccine Institute, Institutes and Centers 2009
Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2009

Contact Information

115 Surg Oncol Res Fac, Durham, NC 27710
Box 2926 Med Ctr, Durham, NC 27710
gflmp@duke.edu (919) 684-2862

Background
Education, Training, & Certifications
- M.D., University of Genoa (Italy) 1985
Duke Appointment History
- Assistant Professor of Surgery, Surgery, Surgical Sciences, Surgery 2006 - 2013
- Assistant Research Professor in Surgery, Surgery, Surgical Sciences, Surgery 2001 - 2006
Academic Positions Outside Duke
- Adjunct Visiting Professor, University of Cape Town. 2012 - 2018
Recognition
In the News
- NOV 27, 2018
  
  Duke Faculty Plentiful On ‘Highly Cited’ List
Expertise
Subject Headings
Global Scholarship
- Research
  - South Africa (Country)
Research
Selected Grants
- EQAPOL - Years 2017 to 2024 - BASE awarded by National Institutes of Health 2017 - 2024
- Targeting Apoptosis and Immune Control of Epstein-Barr Virus Infected Tonsillar B Cells awarded by National Institutes of Health 2016 - 2021
- Interdisciplinary Research Training Program in AIDS awarded by National Institutes of Health 2010 - 2020
- 13th International Conference on HIV Treatment, Pathogenesis, and Prevention Research (Interest) awarded by National Institutes of Health 2019 - 2020
- Nonhuman Primate Option 1 awarded by National Institutes of Health 2018 - 2020
- Infectious Diseases in Africa: Immune Escape and HIV Vaccines awarded by National Institutes of Health 2009 - 2020
- Eqapol Opt 1 -2018-2019 awarded by National Institutes of Health 2017 - 2019
- CARE Focus 1: Latency Biomarker Project awarded by University of North Carolina - Chapel Hill 2018 - 2019
- CARE Focus 2: Clearance of HIV Antigen-Positive Cells awarded by University of North Carolina - Chapel Hill 2016 - 2019
- Dual-Affinity Re-Targeting Proteins for Cure of Newborn Infant HIV-1 Infection awarded by National Institutes of Health 2016 - 2019
- Creation of a bnAbnectin awarded by ViiV Healthcare 2017 - 2019
- IGM Proposal awarded by IGM Biosciences, Inc. 2016 - 2019
- 2018 INTEREST Conference awarded by National Institutes of Health 2018 - 2019
- Project 2: Synthetic DNA & Novel Env Vaccine for HIV awarded by Wistar Institute of Anatomy and Biology 2015 - 2019
- HIV Vaccine Trials Network: LC P5 PF awarded by Fred Hutchinson Cancer Research Center 2015 - 2018
- HVTN - A004 awarded by Fred Hutchinson Cancer Research Center 2015 - 2018
- Evaluation of the host immune response and viral molecular phenotype in lung transplant recipients with PTLD awarded by Mount Sinai School of Medicine 2017 - 2018
- Impact of Fc N-glycan structure on HIV-specific antibody functions awarded by University of Wyoming 2016 - 2018
- CARE Duke-UNC Latency Biomarker Supplement Year 2 awarded by University of North Carolina - Chapel Hill 2016 - 2018
- 2017 INTEREST Conference awarded by National Institutes of Health 2017 - 2018
- Nonhuman Primate Core-Option 6 awarded by National Institutes of Health 2012 - 2018
- EQAPOL - Option 6 - 2016 to 2017 - ELISPOT awarded by National Institutes of Health 2010 - 2017
- EQAPOL Option 5 awarded by National Institutes of Health 2010 - 2017
- Focus 1: Detection of HIV Antigen-Positive Cells awarded by University of North Carolina - Chapel Hill 2016 - 2017
- Invitro Function of DART Molecules (Base) awarded by MacroGenics, Inc. 2016 - 2017
- Infant immune correlates of perinatal mother to child transmission of HIV awarded by National Institutes of Health 2015 - 2017
- Intervening with Latent HIV-1 Infection using Gnidimacrin awarded by National Institutes of Health 2014 - 2017
- 10th INTEREST Workshop on HIV awarded by National Institutes of Health 2016 - 2017
- HIV Vaccine Trials Network: LC P5 PF awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- LC: HIV Vaccine Trials Network: Phase 1 PF awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- Vaccine-induced HIV antibody responses in infants awarded by National Institutes of Health 2012 - 2015
- HIV-1 Gene Suppression by CD8+ T Cells awarded by National Institutes of Health 2002 - 2015
- AIDS International Training and Research Program awarded by National Institutes of Health 2003 - 2014
- Poly-functional analyses of vaccine-induced T cell responses awarded by National Institutes of Health 2001 - 2012
- Correlates of Vaccine Protection Workshop awarded by National Institutes of Health 2010 - 2011
- International Clinical Trials Unit awarded by National Institutes of Health 2004 - 2009
- Infectious Diseases in Africa: Measurement of Immune Responses awarded by National Institutes of Health 2007 - 2008
- Central Laboratory for the HIV Vaccines Trial Network awarded by National Institutes of Health 2000 - 2006
- NCRR FACSAria Cell Sorter awarded by National Center for Research Resources 2004 - 2006
- Anti-Hiv Ctl And Hiv Suppressive Cd8 Cells awarded by National Institutes of Health 1990 - 2000
- Anti-Hiv Ctl And Hiv-Suppresive Cd8+ Cells awarded by National Institutes of Health 1996 - 1999
- Anti-Hiv Ctl And Hiv Suppresive Cd8+ Cells awarded by National Institutes of Health 1995 - 1999
- Antihiv Ctl And Hiv Suppressive Cd8 Cells awarded by National Institutes of Health 1990 - 1999
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Pollara, J, Jones, DI, Huffman, T, Edwards, RW, Dennis, M, Li, SH, Jha, S, Goodman, D, Kumar, A, LaBranche, CC, Montefiori, DC, Fouda, GG, Hope, TJ, Tomaras, GD, Staats, HF, Ferrari, G, and Permar, SR. "Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models." Journal of Virology 93, no. 10 (May 2019). Full Text
  - Pardi, N, LaBranche, CC, Ferrari, G, Cain, DW, Tombácz, I, Parks, RJ, Muramatsu, H, Mui, BL, Tam, YK, Karikó, K, Polacino, P, Barbosa, CJ, Madden, TD, Hope, MJ, Haynes, BF, Montefiori, DC, Hu, S-L, and Weissman, D. "Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques." Molecular Therapy. Nucleic Acids 15 (April 2019): 36-47. Full Text
  - Curtis, AD, Walter, KA, Nabi, R, Jensen, K, Dwivedi, A, Pollara, J, Ferrari, G, Van Rompay, KKA, Amara, RR, Kozlowski, PA, and De Paris, K. "Oral Coadministration of an Intramuscular DNA/Modified Vaccinia Ankara Vaccine for Simian Immunodeficiency Virus Is Associated with Better Control of Infection in Orally Exposed Infant Macaques." Aids Research and Human Retroviruses 35, no. 3 (March 2019): 310-325. Full Text
  - Dennis, M, Eudailey, J, Pollara, J, McMillan, AS, Cronin, KD, Saha, PT, Curtis, AD, Hudgens, MG, Fouda, GG, Ferrari, G, Alam, M, Van Rompay, KKA, De Paris, K, Permar, S, and Shen, X. "Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques." Journal of Virology 93, no. 5 (March 2019). Full Text
  - Kibler, KV, Asbach, B, Perdiguero, B, García-Arriaza, J, Yates, NL, Parks, R, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Tomaras, GD, Roederer, M, Foulds, KE, Forthal, DN, Seaman, MS, Self, S, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, S, Cristillo, AD, Weiss, D, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Wagner, R, Pantaleo, G, and Jacobs, BL. "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC." Journal of Virology 93, no. 3 (February 2019). Full Text
  - Pantaleo, G, Janes, H, Karuna, S, Grant, S, Ouedraogo, L, Allen, M, Tomaras, GD, Frahm, N, Montefiori, DC, Ferrari, G, Ding, S, Lee, C, Robb, ML, Esteban, M, Wagner, R, Alexandre-Bart, P, Rettby, N, McElrath, MJ, Gilbert, PB, Kublin, J, Corey, L, and Trials Network, NIAIDHIVV. "Co-Administration of HIV Env Protein with DNA and/or NYVAC Vaccines in Humans Results in Earlier and Potent Generation of Anti-Env Antibody Responses." (January 25, 2019).
  - Spearman, P, Tomaras, GD, Montefiori, DC, Huang, Y, Elizaga, ML, Ferrari, G, Alam, SM, Isaacs, A, Ahmed, H, Hural, J, McElrath, MJ, Ouedraogo, L, Pensiero, M, Butler, C, Kalams, SA, Overton, ET, Barnett, SW, HVTN 088 Protocol Team, , and NIH/NIAID HIV Vaccine Trials Network, . "Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest." The Journal of Infectious Diseases (January 7, 2019). Full Text
  - van Eeden, C, Wibmer, CK, Scheepers, C, Richardson, SI, Nonyane, M, Lambson, B, Mkhize, NN, Vijayakumar, B, Sheng, Z, Stanfield-Oakley, S, Bhiman, JN, Bekker, V, Hermanus, T, Mabvakure, B, Ismail, A, Moody, MA, Wiehe, K, Garrett, N, Karim, SA, Dirr, H, Fernandes, MA, Sayed, Y, Shapiro, L, Ferrari, G, Haynes, BF, Moore, PL, and Morris, L. "V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity." Cell Reports 25, no. 11 (December 2018): 3123-3135.e6. Full Text
  - Himes, JE, Goswami, R, Mangan, RJ, Kumar, A, Jeffries, TL, Eudailey, JA, Heimsath, H, Nguyen, QN, Pollara, J, LaBranche, C, Chen, M, Vandergrift, NA, Peacock, JW, Schiro, F, Midkiff, C, Ferrari, G, Montefiori, DC, Hernandez, XA, Aye, PP, and Permar, SR. "Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys." Mucosal Immunology 11, no. 6 (November 2018): 1716-1726. Full Text
  - Bradley, T, Ferrari, G, Haynes, BF, Margolis, DM, and Browne, EP. "Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency." Cell Reports 25, no. 1 (October 2018): 107-117.e3. Full Text
  - Bradley, T, Peppa, D, Pedroza-Pacheco, I, Li, D, Cain, DW, Henao, R, Venkat, V, Hora, B, Chen, Y, Vandergrift, NA, Overman, RG, Edwards, RW, Woods, CW, Tomaras, GD, Ferrari, G, Ginsburg, GS, Connors, M, Cohen, MS, Moody, MA, Borrow, P, and Haynes, BF. "RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses." Cell 175, no. 2 (October 2018): 387-399.e17. Full Text
  - Phillips, B, Van Rompay, KKA, Rodriguez-Nieves, J, Lorin, C, Koutsoukos, M, Tomai, M, Fox, CB, Eudailey, J, Dennis, M, Alam, SM, Hudgens, M, Fouda, G, Pollara, J, Moody, A, Shen, X, Ferrari, G, Permar, S, and De Paris, K. "Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques." Journal of Virology 92, no. 20 (October 2018). Full Text
  - Singh, S, Ramírez-Salazar, EG, Doueiri, R, Valentin, A, Rosati, M, Hu, X, Keele, BF, Shen, X, Tomaras, GD, Ferrari, G, LaBranche, C, Montefiori, DC, Das, J, Alter, G, Trinh, HV, Hamlin, C, Rao, M, Dayton, F, Bear, J, Chowdhury, B, Alicea, C, Lifson, JD, Broderick, KE, Sardesai, NY, Sivananthan, SJ, Fox, CB, Reed, SG, Venzon, DJ, Hirsch, VM, Pavlakis, GN, and Felber, BK. "Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques." Journal of Virology 92, no. 15 (August 2018). Full Text
  - Naggie, S, Swiderska-Syn, M, Choi, S, Lusk, S, Lan, A, Ferrari, G, Syn, W-K, Guy, CD, and Diehl, AM. "Markers of Tissue Repair and Cellular Aging Are Increased in the Liver Tissue of Patients With HIV Infection Regardless of Presence of HCV Coinfection." Open Forum Infectious Diseases 5, no. 7 (July 2018): ofy138-null. Full Text
  - Ferrari, G. "Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment." The Journal of Clinical Investigation 128, no. 6 (June 2018): 2189-2191. Full Text
  - Garrido, C, Abad-Fernandez, M, Tuyishime, M, Pollara, JJ, Ferrari, G, Soriano-Sarabia, N, and Margolis, DM. "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo." Journal of Virology 92, no. 12 (June 2018). Full Text
  - Pollara, J, Orlandi, C, Beck, C, Edwards, RW, Hu, Y, Liu, S, Wang, S, Koup, RA, Denny, TN, Lu, S, Tomaras, GD, DeVico, A, Lewis, GK, and Ferrari, G. "Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay." Cytometry. Part a : the Journal of the International Society for Analytical Cytology 93, no. 4 (April 2018): 436-447. Full Text Open Access Copy
  - Saunders, KO, Santra, S, Parks, R, Yates, NL, Sutherland, LL, Scearce, RM, Balachandran, H, Bradley, T, Goodman, D, Eaton, A, Stanfield-Oakley, SA, Tartaglia, J, Phogat, S, Pantaleo, G, Esteban, M, Gomez, CE, Perdiguero, B, Jacobs, B, Kibler, K, Korber, B, Montefiori, DC, Ferrari, G, Vandergrift, N, Liao, H-X, Tomaras, GD, and Haynes, BF. "Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates." Journal of Virology 92, no. 8 (April 2018). Full Text
  - Wills, S, Hwang, K-K, Liu, P, Dennison, SM, Tay, MZ, Shen, X, Pollara, J, Lucas, JT, Parks, R, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Kaewkungwal, J, Thomas, R, Kim, JH, Michael, NL, Robb, ML, McRaven, M, Montefiori, DC, Hope, TJ, Liao, H-X, Moody, MA, Ferrari, G, Haynes, BF, Alam, SM, Bonsignori, M, and Tomaras, GD. "HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis." Journal of Virology 92, no. 7 (April 2018). Full Text
  - Fong, Y, Shen, X, Ashley, VC, Deal, A, Seaton, KE, Yu, C, Grant, SP, Ferrari, G, deCamp, AC, Bailer, RT, Koup, RA, Montefiori, D, Haynes, BF, Sarzotti-Kelsoe, M, Graham, BS, Carpp, LN, Hammer, SM, Sobieszczyk, M, Karuna, S, Swann, E, DeJesus, E, Mulligan, M, Frank, I, Buchbinder, S, Novak, RM, McElrath, MJ, Kalams, S, Keefer, M, Frahm, NA, Janes, HE, Gilbert, PB, and Tomaras, GD. "Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial." The Journal of Infectious Diseases 217, no. 8 (March 2018): 1280-1288. Full Text
  - Jones, AT, Chamcha, V, Kesavardhana, S, Shen, X, Beaumont, D, Das, R, Wyatt, LS, LaBranche, CC, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Moss, B, Tomaras, GD, Varadarajan, R, and Amara, RR. "A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques." Journal of Virology 92, no. 5 (March 2018). Full Text
  - Viegas, EO, Tembe, N, Nilsson, C, Meggi, B, Maueia, C, Augusto, O, Stout, R, Scarlatti, G, Ferrari, G, Earl, PL, Wahren, B, Andersson, S, Robb, ML, Osman, N, Biberfeld, G, Jani, I, and Sandström, E. "Intradermal HIV-1 DNA Immunization Using Needle-Free Zetajet Injection Followed by HIV-Modified Vaccinia Virus Ankara Vaccination Is Safe and Immunogenic in Mozambican Young Adults: A Phase I Randomized Controlled Trial." Aids Research and Human Retroviruses 34, no. 2 (February 2018): 193-205. Full Text
  - Eudailey, JA, Dennis, ML, Parker, ME, Phillips, BL, Huffman, TN, Bay, CP, Hudgens, MG, Wiseman, RW, Pollara, JJ, Fouda, GG, Ferrari, G, Pickup, DJ, Kozlowski, PA, Van Rompay, KKA, De Paris, K, and Permar, SR. "Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques." Msphere 3, no. 1 (January 10, 2018). Full Text Open Access Copy
  - Blasi, M, Negri, D, LaBranche, C, Alam, SM, Baker, EJ, Brunner, EC, Gladden, MA, Michelini, Z, Vandergrift, NA, Wiehe, KJ, Parks, R, Shen, X, Bonsignori, M, Tomaras, GD, Ferrari, G, Montefiori, DC, Santra, S, Haynes, BF, Moody, MA, Cara, A, and Klotman, ME. "IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells." Communications Biology 1 (January 2018): 134-null. Full Text Open Access Copy
  - Shen, X, Basu, R, Sawant, S, Beaumont, D, Kwa, SF, LaBranche, C, Seaton, KE, Yates, NL, Montefiori, DC, Ferrari, G, Wyatt, LS, Moss, B, Alam, SM, Haynes, BF, Tomaras, GD, and Robinson, HL. "HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine." Journal of Virology 91, no. 24 (December 2017). Full Text
  - Francica, JR, Zak, DE, Linde, C, Siena, E, Johnson, C, Juraska, M, Yates, NL, Gunn, B, De Gregorio, E, Flynn, BJ, Valiante, NM, Malyala, P, Barnett, SW, Sarkar, P, Singh, M, Jain, S, Ackerman, M, Alam, M, Ferrari, G, Salazar, A, Tomaras, GD, O'Hagan, DT, Aderem, A, Alter, G, and Seder, RA. "Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs." Blood Advances 1, no. 25 (November 17, 2017): 2329-2342. Full Text
  - Mayer, KH, Seaton, KE, Huang, Y, Grunenberg, N, Isaacs, A, Allen, M, Ledgerwood, JE, Frank, I, Sobieszczyk, ME, Baden, LR, Rodriguez, B, Van Tieu, H, Tomaras, GD, Deal, A, Goodman, D, Bailer, RT, Ferrari, G, Jensen, R, Hural, J, Graham, BS, Mascola, JR, Corey, L, Montefiori, DC, HVTN 104 Protocol Team, , and and the NIAID HIV Vaccine Trials Network, . "Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial." Plos Medicine 14, no. 11 (November 14, 2017): e1002435-null. Full Text
  - Liu, D, Wang, C, Hora, B, Zuo, T, Goonetilleke, N, Liu, MKP, Berrong, M, Ferrari, G, McMichael, AJ, Bhattacharya, T, Perelson, AS, and Gao, F. "A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies." Retrovirology 14, no. 1 (October 10, 2017): 46-null. Full Text
  - Phillips, B, Fouda, GG, Eudailey, J, Pollara, J, Curtis, AD, Kunz, E, Dennis, M, Shen, X, Bay, C, Hudgens, M, Pickup, D, Alam, SM, Ardeshir, A, Kozlowski, PA, Van Rompay, KKA, Ferrari, G, Moody, MA, Permar, S, and De Paris, K. "Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques." Clinical and Vaccine Immunology : Cvi 24, no. 10 (October 5, 2017). Full Text
  - Bogers, WMJM, Barnett, SW, Oostermeijer, H, Nieuwenhuis, IG, Beenhakker, N, Mortier, D, Mooij, P, Koopman, G, Remarque, E, Martin, G, Lai, RP-J, Dey, AK, Sun, Y, Burke, B, Ferrari, G, Montefiori, D, Martin, L, Davis, D, Srivastava, I, and Heeney, JL. "Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site." Journal of Virology 91, no. 19 (October 2017). Full Text
  - Shen, X, Bogers, WM, Yates, NL, Ferrari, G, Dey, AK, Williams, WT, Jaeger, FH, Wiehe, K, Sawant, S, Alam, SM, LaBranche, CC, Montefiori, DC, Martin, L, Srivastava, I, Heeney, J, Barnett, SW, and Tomaras, GD. "Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques." Journal of Virology 91, no. 19 (October 2017). Full Text
  - Joachim, A, Munseri, PJ, Nilsson, C, Bakari, M, Aboud, S, Lyamuya, EF, Tecleab, T, Liakina, V, Scarlatti, G, Robb, ML, Earl, PL, Moss, B, Wahren, B, Mhalu, F, Ferrari, G, Sandstrom, E, and Biberfeld, G. "Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers." Aids Research and Human Retroviruses 33, no. 8 (August 2017): 880-888. Full Text
  - Lewis, GK, Pazgier, M, Evans, DT, Ferrari, G, Bournazos, S, Parsons, MS, Bernard, NF, and Finzi, A. "Beyond Viral Neutralization." Aids Research and Human Retroviruses 33, no. 8 (August 2017): 760-764. (Review) Full Text
  - Meyerhoff, RR, Scearce, RM, Ogburn, DF, Lockwood, B, Pickeral, J, Kuraoka, M, Anasti, K, Eudailey, J, Eaton, A, Cooper, M, Wiehe, K, Montefiori, DC, Tomaras, G, Ferrari, G, Alam, SM, Liao, H-X, Korber, B, Gao, F, and Haynes, BF. "HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies." Aids Research and Human Retroviruses 33, no. 8 (August 2017): 859-868. Full Text
  - Bradley, T, Pollara, J, Santra, S, Vandergrift, N, Pittala, S, Bailey-Kellogg, C, Shen, X, Parks, R, Goodman, D, Eaton, A, Balachandran, H, Mach, LV, Saunders, KO, Weiner, JA, Scearce, R, Sutherland, LL, Phogat, S, Tartaglia, J, Reed, SG, Hu, S-L, Theis, JF, Pinter, A, Montefiori, DC, Kepler, TB, Peachman, KK, Rao, M, Michael, NL, Suscovich, TJ, Alter, G, Ackerman, ME, Moody, MA, Liao, H-X, Tomaras, G, Ferrari, G, Korber, BT, and Haynes, BF. "Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge." Nature Communications 8 (June 8, 2017): 15711-null. Full Text
  - Shubin, Z, Li, W, Poonia, B, Ferrari, G, LaBranche, C, Montefiori, D, Zhu, X, and Pauza, CD. "An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques." Clinical and Vaccine Immunology : Cvi 24, no. 6 (June 5, 2017). Full Text
  - Wang, C, Jiang, C, Gao, N, Zhang, K, Liu, D, Wang, W, Cong, Z, Qin, C, Ganusov, VV, Ferrari, G, LaBranche, C, Montefiori, DC, Kong, W, Yu, X, and Gao, F. "Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine." Viruses 9, no. 6 (June 2, 2017). Full Text
  - García-Arriaza, J, Perdiguero, B, Heeney, JL, Seaman, MS, Montefiori, DC, Yates, NL, Tomaras, GD, Ferrari, G, Foulds, KE, Roederer, M, Self, SG, Borate, B, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, AD, Weiss, DE, Lee, C, Kibler, KV, Jacobs, BL, Wagner, R, Ding, S, Pantaleo, G, and Esteban, M. "HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates." Journal of Virology 91, no. 9 (May 2017). Full Text
  - Zurawski, G, Shen, X, Zurawski, S, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Lacabaratz, C, Klucar, P, Wang, Z, Foulds, KE, Kao, S-F, Yu, X, Sato, A, Yates, NL, LaBranche, C, Stanfield-Oakley, S, Kibler, K, Jacobs, B, Salazar, A, Self, S, Fulp, W, Gottardo, R, Galmin, L, Weiss, D, Cristillo, A, Pantaleo, G, and Levy, Y. "Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses." Journal of Virology 91, no. 9 (May 2017). Full Text
  - Ferrari, G, Pollara, J, Tomaras, GD, and Haynes, BF. "Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection." The Journal of Infectious Diseases 215, no. suppl_3 (March 2017): S152-S159. (Review) Full Text
  - Easterhoff, D, Moody, MA, Fera, D, Cheng, H, Ackerman, M, Wiehe, K, Saunders, KO, Pollara, J, Vandergrift, N, Parks, R, Kim, J, Michael, NL, O'Connell, RJ, Excler, J-L, Robb, ML, Vasan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Nitayaphan, S, Sinangil, F, Tartaglia, J, Phogat, S, Kepler, TB, Alam, SM, Liao, H-X, Ferrari, G, Seaman, MS, Montefiori, DC, Tomaras, GD, Harrison, SC, and Haynes, BF. "Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial." Plos Pathogens 13, no. 2 (February 24, 2017): e1006182-null. Full Text
  - Chege, GK, Burgers, WA, Müller, TL, Gray, CM, Shephard, EG, Barnett, SW, Ferrari, G, Montefiori, D, Williamson, C, and Williamson, A-L. "DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies." Vaccine 35, no. 6 (February 2017): 929-937. Full Text
  - Buchbinder, SP, Grunenberg, NA, Sanchez, BJ, Seaton, KE, Ferrari, G, Moody, MA, Frahm, N, Montefiori, DC, Hay, CM, Goepfert, PA, Baden, LR, Robinson, HL, Yu, X, Gilbert, PB, McElrath, MJ, Huang, Y, Tomaras, GD, and HIV Vaccine Trials Network (HVTN) 094 Study Group, . "Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults." Plos One 12, no. 7 (January 2017): e0179597-null. Full Text
  - Ferrari, G. "Meet our editorial board member." Current Hiv Research 15, no. 1 (January 1, 2017): 1-null. Full Text
  - Hankins, CA, Koulla-Shiro, S, Kilmarx, P, Ferrari, G, Schechter, M, Kane, CT, Venter, F, Boucher, CA, Ross, A-L, Zewdie, D, Eholié, SP, and Katabira, E. "Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon." Antiviral Therapy 22, no. 2 (January 2017): 179-184. Full Text
  - Margolis, DM, Koup, RA, and Ferrari, G. "HIV antibodies for treatment of HIV infection." Immunological Reviews 275, no. 1 (January 2017): 313-323. (Review) Full Text
  - Luo, K, Liao, H-X, Zhang, R, Easterhoff, D, Wiehe, K, Gurley, TC, Armand, LC, Allen, AA, Von Holle, TA, Marshall, DJ, Whitesides, JF, Pritchett, J, Foulger, A, Hernandez, G, Parks, R, Lloyd, KE, Stolarchuk, C, Sawant, S, Peel, J, Yates, NL, Dunford, E, Arora, S, Wang, A, Bowman, CM, Sutherland, LL, Scearce, RM, Xia, S-M, Bonsignori, M, Pollara, J, Edwards, RW, Santra, S, Letvin, NL, Tartaglia, J, Francis, D, Sinangil, F, Lee, C, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Michael, NL, Kim, JH, Alam, SM, Vandergrift, NA, Ferrari, G, Montefiori, DC, Tomaras, GD, Haynes, BF, and Moody, MA. "Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques." Jci Insight 1, no. 20 (December 8, 2016): e88522-null. Full Text
  - Astronomo, RD, Santra, S, Ballweber-Fleming, L, Westerberg, KG, Mach, L, Hensley-McBain, T, Sutherland, L, Mildenberg, B, Morton, G, Yates, NL, Mize, GJ, Pollara, J, Hladik, F, Ochsenbauer, C, Denny, TN, Warrier, R, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Kaewkungwal, J, Ferrari, G, Shaw, GM, Xia, S-M, Liao, H-X, Montefiori, DC, Tomaras, GD, Haynes, BF, and McElrath, JM. "Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection." Ebiomedicine 14 (December 2016): 97-111. Full Text Open Access Copy
  - Ferrari, G, Haynes, BF, Koenig, S, Nordstrom, JL, Margolis, DM, and Tomaras, GD. "Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection." Nature Reviews. Drug Discovery 15, no. 12 (December 2016): 823-834. (Review) Full Text
  - Huang, Y, Ferrari, G, Alter, G, Forthal, DN, Kappes, JC, Lewis, GK, Love, JC, Borate, B, Harris, L, Greene, K, Gao, H, Phan, TB, Landucci, G, Goods, BA, Dowell, KG, Cheng, HD, Bailey-Kellogg, C, Montefiori, DC, and Ackerman, ME. "Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects." Journal of Immunology (Baltimore, Md. : 1950) 197, no. 12 (December 2016): 4603-4612. Full Text
  - Nemes, E, Burgers, WA, Riou, C, Andersen-Nissen, E, Ferrari, G, Gray, CM, and Scriba, T. "Teaching advanced flow cytometry in Africa: 10 years of lessons learned." Cytometry. Part a : the Journal of the International Society for Analytical Cytology 89, no. 11 (November 4, 2016): 971-974. Full Text
  - Altenburg, AF, van de Sandt, CE, van Trierum, SE, De Gruyter, HLM, van Run, PRWA, Fouchier, RAM, Roose, K, Saelens, X, Volz, A, Sutter, G, de Vries, RD, and Rimmelzwaan, GF. "Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice." Journal of Virology 90, no. 22 (November 2016): 10209-10219. Full Text
  - Costa, MR, Pollara, J, Edwards, RW, Seaman, MS, Gorny, MK, Montefiori, DC, Liao, H-X, Ferrari, G, Lu, S, and Wang, S. "Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001." Journal of Virology 90, no. 22 (November 2016): 10362-10378. Full Text
  - Gay, CL, Willis, SJ, Cope, AB, Kuruc, JD, McGee, KS, Sebastian, J, Crooks, AM, McKellar, MS, Margolis, DM, Fiscus, SA, Hicks, CB, Ferrari, G, Eron, JJ, and Duke-UNC Acute HIV Infection Consortium, . "Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability." Aids (London, England) 30, no. 18 (November 2016): 2815-2822. Full Text
  - Negri, D, Blasi, M, LaBranche, C, Parks, R, Balachandran, H, Lifton, M, Shen, X, Denny, T, Ferrari, G, Vescio, MF, Andersen, H, Montefiori, DC, Tomaras, GD, Liao, H-X, Santra, S, Haynes, BF, Klotman, ME, and Cara, A. "Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques." Molecular Therapy : the Journal of the American Society of Gene Therapy 24, no. 11 (November 2016): 2021-2032. Full Text Open Access Copy
  - Negri, D, Blasi, M, LaBranche, C, Parks, R, Balachandran, H, Lifton, M, Shen, X, Denny, T, Ferrari, G, Vescio, MF, Andersen, H, Montefiori, DC, Tomaras, GD, Liao, H-X, Santra, S, Haynes, BF, Klotman, ME, and Cara, A. "Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques." MOLECULAR THERAPY 24, no. 11 (November 2016): 2021-2032. Full Text Open Access Copy Link to Item
  - Gordon, SN, Liyanage, NPM, Doster, MN, Vaccari, M, Vargas-Inchaustegui, DA, Pegu, P, Schifanella, L, Shen, X, Tomaras, GD, Rao, M, Billings, EA, Schwartz, J, Prado, I, Bobb, K, Zhang, W, Montefiori, DC, Foulds, KE, Ferrari, G, Robert-Guroff, M, Roederer, M, Phan, TB, Forthal, DN, Stablein, DM, Phogat, S, Venzon, DJ, Fouts, T, and Franchini, G. "Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition." Journal of Immunology (Baltimore, Md. : 1950) 197, no. 7 (October 2016): 2726-2737. Full Text
  - Townsley, S, Mohamed, Z, Guo, W, McKenna, J, Cleveland, B, LaBranche, C, Beaumont, D, Shen, X, Yates, NL, Pinter, A, Tomaras, GD, Ferrari, G, Montefiori, DC, and Hu, S-L. "Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization." Journal of Virology 90, no. 19 (October 2016): 8644-8660. Full Text
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Liyanage, NPM, Cameron, M, Keele, BF, Shen, X, Tomaras, GD, Billings, E, Rao, M, Chung, AW, Dowell, KG, Bailey-Kellogg, C, Brown, EP, Ackerman, ME, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Loré, K, Roederer, M, Koup, RA, McDermott, A, Ma, Z-M, Miller, CJ, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Bissa, M, Ferrari, G, Kalyanaraman, V, Ferrari, MG, Thompson, D, Robert-Guroff, M, Ratto-Kim, S, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Alter, G, Sekaly, R-P, and Franchini, G. "Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition." Nature Medicine 22, no. 10 (October 2016): 1192-null. Full Text
  - Zhang, R, Martinez, DR, Nguyen, QN, Pollara, J, Arifin, T, Stolarchuk, C, Foulger, A, Amos, JD, Parks, R, Himes, JE, Wang, M, Edwards, RW, Trama, AM, Vandergrift, N, Colvin, L, Dewar, K, Juretic, N, Wasserscheid, J, Ferrari, G, Liao, H-X, and Permar, SR. "Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus." Nature Communications 7 (July 6, 2016): 12131-null. Full Text
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Liyanage, NPM, Cameron, M, Keele, BF, Shen, X, Tomaras, GD, Billings, E, Rao, M, Chung, AW, Dowell, KG, Bailey-Kellogg, C, Brown, EP, Ackerman, ME, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Loré, K, Roederer, M, Koup, RA, McDermott, A, Ma, Z-M, Miller, CJ, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Bissa, M, Ferrari, G, Kalyanaraman, V, Ferrari, MG, Thompson, D, Robert-Guroff, M, Ratto-Kim, S, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Alter, G, Sekaly, R-P, and Franchini, G. "Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition." Nature Medicine 22, no. 7 (July 2016): 762-770. Full Text
  - Rountree, W, Berrong, M, Sanchez, AM, Denny, TN, and Ferrari, G. "Variability of the IFN-γ ELISpot assay in the context of proficiency testing and bridging studies." Journal of immunological methods 433 (June 2016): 69-76. Full Text Open Access Copy
  - Nelson, CS, Pollara, J, Kunz, EL, Jeffries, TL, Duffy, R, Beck, C, Stamper, L, Wang, M, Shen, X, Pickup, DJ, Staats, HF, Hudgens, MG, Kepler, TB, Montefiori, DC, Moody, MA, Tomaras, GD, Liao, H-X, Haynes, BF, Ferrari, G, Fouda, GGA, and Permar, SR. "Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk." Journal of Virology 90, no. 10 (May 2016): 4951-4965. Full Text
  - Asbach, B, Kliche, A, Köstler, J, Perdiguero, B, Esteban, M, Jacobs, BL, Montefiori, DC, LaBranche, CC, Yates, NL, Tomaras, GD, Ferrari, G, Foulds, KE, Roederer, M, Landucci, G, Forthal, DN, Seaman, MS, Hawkins, N, Self, SG, Sato, A, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, AD, Weiss, DE, Francis, J, Galmin, L, Ding, S, Heeney, JL, Pantaleo, G, and Wagner, R. "Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens." Journal of Virology 90, no. 8 (April 2016): 4133-4149. Full Text Open Access Copy
  - Jeffries, TL, Sacha, CR, Pollara, J, Himes, J, Jaeger, FH, Dennison, SM, McGuire, E, Kunz, E, Eudailey, JA, Trama, AM, LaBranche, C, Fouda, GG, Wiehe, K, Montefiori, DC, Haynes, BF, Liao, H-X, Ferrari, G, Alam, SM, Moody, MA, and Permar, SR. "The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells." Mucosal Immunology 9, no. 2 (March 2016): 414-427. Full Text
  - Ding, S, Veillette, M, Coutu, M, Prévost, J, Scharf, L, Bjorkman, PJ, Ferrari, G, Robinson, JE, Stürzel, C, Hahn, BH, Sauter, D, Kirchhoff, F, Lewis, GK, Pazgier, M, and Finzi, A. "A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies." Journal of Virology 90, no. 4 (February 2016): 2127-2134. Full Text
  - Cosgrove, CA, Lacey, CJ, Cope, AV, Bartolf, A, Morris, G, Yan, C, Baden, S, Cole, T, Carter, D, Brodnicki, E, Shen, X, Joseph, S, DeRosa, SC, Peng, L, Yu, X, Ferrari, G, Seaman, M, Montefiori, DC, Frahm, N, Tomaras, GD, Stöhr, W, McCormack, S, and Shattock, RJ. "Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study." Plos One 11, no. 5 (January 2016): e0152038-null. Full Text
  - Joachim, A, Bauer, A, Joseph, S, Geldmacher, C, Munseri, PJ, Aboud, S, Missanga, M, Mann, P, Wahren, B, Ferrari, G, Polonis, VR, Robb, ML, Weber, J, Tatoud, R, Maboko, L, Hoelscher, M, Lyamuya, EF, Biberfeld, G, Sandström, E, Kroidl, A, Bakari, M, Nilsson, C, and McCormack, S. "Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial." Plos One 11, no. 5 (January 2016): e0155702-null. Full Text
  - Zurawski, G, Zurawski, S, Flamar, A-L, Richert, L, Wagner, R, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Lacabaratz, C, Bonnabau, H, Klucar, P, Wang, Z, Foulds, KE, Kao, S-F, Yates, NL, LaBranche, C, Jacobs, BL, Kibler, K, Asbach, B, Kliche, A, Salazar, A, Reed, S, Self, S, Gottardo, R, Galmin, L, Weiss, D, Cristillo, A, Thiebaut, R, Pantaleo, G, and Levy, Y. "Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques." Plos One 11, no. 4 (January 2016): e0153484-null. Full Text
  - Lai, W, Huang, L, Zhu, L, Ferrari, G, Chan, C, Li, W, Lee, K-H, and Chen, C-H. "Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β." Journal of Medicinal Chemistry 58, no. 21 (November 3, 2015): 8638-8646. Full Text
  - Sung, JAM, Pickeral, J, Liu, L, Stanfield-Oakley, SA, Lam, C-YK, Garrido, C, Pollara, J, LaBranche, C, Bonsignori, M, Moody, MA, Yang, Y, Parks, R, Archin, N, Allard, B, Kirchherr, J, Kuruc, JD, Gay, CL, Cohen, MS, Ochsenbauer, C, Soderberg, K, Liao, H-X, Montefiori, D, Moore, P, Johnson, S, Koenig, S, Haynes, BF, Nordstrom, JL, Margolis, DM, and Ferrari, G. "Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells." The Journal of Clinical Investigation 125, no. 11 (November 2015): 4077-4090. Full Text
  - Pollara, J, McGuire, E, Fouda, GG, Rountree, W, Eudailey, J, Overman, RG, Seaton, KE, Deal, A, Edwards, RW, Tegha, G, Kamwendo, D, Kumwenda, J, Nelson, JAE, Liao, H-X, Brinkley, C, Denny, TN, Ochsenbauer, C, Ellington, S, King, CC, Jamieson, DJ, van der Horst, C, Kourtis, AP, Tomaras, GD, Ferrari, G, and Permar, SR. "Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1." Journal of Virology 89, no. 19 (October 2015): 9952-9961. Full Text Open Access Copy
  - Moody, MA, Gao, F, Gurley, TC, Amos, JD, Kumar, A, Hora, B, Marshall, DJ, Whitesides, JF, Xia, S-M, Parks, R, Lloyd, KE, Hwang, K-K, Lu, X, Bonsignori, M, Finzi, A, Vandergrift, NA, Alam, SM, Ferrari, G, Shen, X, Tomaras, GD, Kamanga, G, Cohen, MS, Sam, NE, Kapiga, S, Gray, ES, Tumba, NL, Morris, L, Zolla-Pazner, S, Gorny, MK, Mascola, JR, Hahn, BH, Shaw, GM, Sodroski, JG, Liao, H-X, Montefiori, DC, Hraber, PT, Korber, BT, and Haynes, BF. "Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses." Cell Host & Microbe 18, no. 3 (September 2015): 354-362. Full Text
  - Wise, MC, Hutnick, NA, Pollara, J, Myles, DJF, Williams, C, Yan, J, LaBranche, CC, Khan, AS, Sardesai, NY, Montefiori, D, Barnett, SW, Zolla-Pazner, S, Ferrari, G, and Weiner, DB. "An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates." Journal of Virology 89, no. 18 (September 2015): 9154-9166. Full Text
  - Santra, S, Tomaras, GD, Warrier, R, Nicely, NI, Liao, H-X, Pollara, J, Liu, P, Alam, SM, Zhang, R, Cocklin, SL, Shen, X, Duffy, R, Xia, S-M, Schutte, RJ, Pemble Iv, CW, Dennison, SM, Li, H, Chao, A, Vidnovic, K, Evans, A, Klein, K, Kumar, A, Robinson, J, Landucci, G, Forthal, DN, Montefiori, DC, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Robb, ML, Michael, NL, Kim, JH, Soderberg, KA, Giorgi, EE, Blair, L, Korber, BT, Moog, C, Shattock, RJ, Letvin, NL, Schmitz, JE, Moody, MA, Gao, F, Ferrari, G, Shaw, GM, and Haynes, BF. "Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques." Plos Pathogens 11, no. 8 (August 3, 2015): e1005042-null. Full Text Open Access Copy
  - García-Arriaza, J, Perdiguero, B, Heeney, J, Seaman, M, Montefiori, DC, Labranche, C, Yates, NL, Shen, X, Tomaras, GD, Ferrari, G, Foulds, KE, McDermott, A, Kao, S-F, Roederer, M, Hawkins, N, Self, S, Yao, J, Farrell, P, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, A, Weiss, D, Lee, C, Kibler, K, Jacobs, B, Asbach, B, Wagner, R, Ding, S, Pantaleo, G, and Esteban, M. "Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates." Journal of Virology 89, no. 16 (August 2015): 8525-8539. Full Text
  - Williams, WB, Liao, H-X, Moody, MA, Kepler, TB, Alam, SM, Gao, F, Wiehe, K, Trama, AM, Jones, K, Zhang, R, Song, H, Marshall, DJ, Whitesides, JF, Sawatzki, K, Hua, A, Liu, P, Tay, MZ, Seaton, KE, Shen, X, Foulger, A, Lloyd, KE, Parks, R, Pollara, J, Ferrari, G, Yu, J-S, Vandergrift, N, Montefiori, DC, Sobieszczyk, ME, Hammer, S, Karuna, S, Gilbert, P, Grove, D, Grunenberg, N, McElrath, MJ, Mascola, JR, Koup, RA, Corey, L, Nabel, GJ, Morgan, C, Churchyard, G, Maenza, J, Keefer, M, Graham, BS, Baden, LR, Tomaras, GD, and Haynes, BF. "HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies." Science (New York, N.Y.) 349, no. 6249 (August 2015): aab1253-null. Full Text
  - Permar, SR, Fong, Y, Vandergrift, N, Fouda, GG, Gilbert, P, Parks, R, Jaeger, FH, Pollara, J, Martelli, A, Liebl, BE, Lloyd, K, Yates, NL, Overman, RG, Shen, X, Whitaker, K, Chen, H, Pritchett, J, Solomon, E, Friberg, E, Marshall, DJ, Whitesides, JF, Gurley, TC, Von Holle, T, Martinez, DR, Cai, F, Kumar, A, Xia, S-M, Lu, X, Louzao, R, Wilkes, S, Datta, S, Sarzotti-Kelsoe, M, Liao, H-X, Ferrari, G, Alam, SM, Montefiori, DC, Denny, TN, Moody, MA, Tomaras, GD, Gao, F, and Haynes, BF. "Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission." The Journal of Clinical Investigation 125, no. 7 (July 2015): 2702-2706. Full Text Open Access Copy
  - Prentice, HA, Tomaras, GD, Geraghty, DE, Apps, R, Fong, Y, Ehrenberg, PK, Rolland, M, Kijak, GH, Krebs, SJ, Nelson, W, DeCamp, A, Shen, X, Yates, NL, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Ferrari, G, McElrath, MJ, Montefiori, DC, Bailer, RT, Koup, RA, O'Connell, RJ, Robb, ML, Michael, NL, Gilbert, PB, Kim, JH, and Thomas, R. "HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition." Science Translational Medicine 7, no. 296 (July 2015): 296ra112-null. Full Text
  - Hancock, G, Yang, H, Yorke, E, Wainwright, E, Bourne, V, Frisbee, A, Payne, TL, Berrong, M, Ferrari, G, Chopera, D, Hanke, T, Mothe, B, Brander, C, McElrath, MJ, McMichael, A, Goonetilleke, N, Tomaras, GD, Frahm, N, and Dorrell, L. "Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses." Plos Pathogens 11, no. 2 (February 27, 2015): e1004658-null. Full Text
  - Fouda, GG, Cunningham, CK, McFarland, EJ, Borkowsky, W, Muresan, P, Pollara, J, Song, LY, Liebl, BE, Whitaker, K, Shen, X, Vandergrift, NA, Overman, RG, Yates, NL, Moody, MA, Fry, C, Kim, JH, Michael, NL, Robb, M, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Liao, H-X, Haynes, BF, Montefiori, DC, Ferrari, G, Tomaras, GD, and Permar, SR. "Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses." The Journal of Infectious Diseases 211, no. 4 (February 2015): 508-517. Full Text
  - Joachim, A, Nilsson, C, Aboud, S, Bakari, M, Lyamuya, EF, Robb, ML, Marovich, MA, Earl, P, Moss, B, Ochsenbauer, C, Wahren, B, Mhalu, F, Sandström, E, Biberfeld, G, Ferrari, G, and Polonis, VR. "Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults." Plos One 10, no. 4 (January 2015): e0118486-null. Full Text Open Access Copy
  - Gordon, SN, Doster, MN, Kines, RC, Keele, BF, Brocca-Cofano, E, Guan, Y, Pegu, P, Liyanage, NPM, Vaccari, M, Cuburu, N, Buck, CB, Ferrari, G, Montefiori, D, Piatak, M, Lifson, JD, Xenophontos, AM, Venzon, D, Robert-Guroff, M, Graham, BS, Lowy, DR, Schiller, JT, and Franchini, G. "Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia." Journal of Immunology (Baltimore, Md. : 1950) 193, no. 12 (December 2014): 6172-6183. Full Text
  - Stieh, DJ, King, DF, Klein, K, Liu, P, Shen, X, Hwang, KK, Ferrari, G, Montefiori, DC, Haynes, B, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Michael, NL, Robb, ML, Kim, JH, Denny, TN, Tomaras, GD, and Shattock, RJ. "Aggregate complexes of HIV-1 induced by multimeric antibodies." Retrovirology 11 (October 2, 2014): 78-null. Full Text Open Access Copy
  - Li, SS, Gilbert, PB, Tomaras, GD, Kijak, G, Ferrari, G, Thomas, R, Pyo, C-W, Zolla-Pazner, S, Montefiori, D, Liao, H-X, Nabel, G, Pinter, A, Evans, DT, Gottardo, R, Dai, JY, Janes, H, Morris, D, Fong, Y, Edlefsen, PT, Li, F, Frahm, N, Alpert, MD, Prentice, H, Rerks-Ngarm, S, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Robb, ML, O'Connell, RJ, Haynes, BF, Michael, NL, Kim, JH, McElrath, MJ, and Geraghty, DE. "FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial." The Journal of Clinical Investigation 124, no. 9 (September 2014): 3879-3890. Full Text
  - Payne, TL, Blackinton, J, Frisbee, A, Pickeral, J, Sawant, S, Vandergrift, NA, Freel, SA, Ferrari, G, Keene, JD, and Tomaras, GD. "Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition." Journal of Virology 88, no. 17 (September 2014): 9514-9528. Full Text
  - Dennison, SM, Anasti, KM, Jaeger, FH, Stewart, SM, Pollara, J, Liu, P, Kunz, EL, Zhang, R, Vandergrift, N, Permar, S, Ferrari, G, Tomaras, GD, Bonsignori, M, Michael, NL, Kim, JH, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Liao, H-X, Haynes, BF, and Alam, SM. "Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide." Journal of Virology 88, no. 16 (August 2014): 9406-9417. Full Text
  - Gao, F, Bonsignori, M, Liao, H-X, Kumar, A, Xia, S-M, Lu, X, Cai, F, Hwang, K-K, Song, H, Zhou, T, Lynch, RM, Alam, SM, Moody, MA, Ferrari, G, Berrong, M, Kelsoe, G, Shaw, GM, Hahn, BH, Montefiori, DC, Kamanga, G, Cohen, MS, Hraber, P, Kwong, PD, Korber, BT, Mascola, JR, Kepler, TB, and Haynes, BF. "Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies." Cell 158, no. 3 (July 24, 2014): 481-491. Full Text
  - Garcia, A, Keinonen, S, Sanchez, AM, Ferrari, G, Denny, TN, and Moody, MA. "Leukopak PBMC sample processing for preparing quality control material to support proficiency testing programs." Journal of Immunological Methods 409 (July 2014): 99-106. Full Text Open Access Copy
  - Haynes, BF, Moody, MA, Alam, M, Bonsignori, M, Verkoczy, L, Ferrari, G, Gao, F, Tomaras, GD, Liao, H-X, and Kelsoe, G. "Progress in HIV-1 vaccine development." The Journal of Allergy and Clinical Immunology 134, no. 1 (July 2014): 3-11. (Review) Full Text
  - Pollara, J, Bonsignori, M, Moody, MA, Liu, P, Alam, SM, Hwang, K-K, Gurley, TC, Kozink, DM, Armand, LC, Marshall, DJ, Whitesides, JF, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Robb, ML, O'Connell, RJ, Kim, JH, Michael, NL, Montefiori, DC, Tomaras, GD, Liao, H-X, Haynes, BF, and Ferrari, G. "HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities." Journal of Virology 88, no. 14 (July 2014): 7715-7726. Full Text
  - Sambor, A, Garcia, A, Berrong, M, Pickeral, J, Brown, S, Rountree, W, Sanchez, A, Pollara, J, Frahm, N, Keinonen, S, Kijak, GH, Roederer, M, Levine, G, D'Souza, MP, Jaimes, M, Koup, R, Denny, T, Cox, J, and Ferrari, G. "Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials." Journal of immunological methods 409 (July 2014): 107-116. Full Text Open Access Copy
  - Sanchez, AM, Rountree, W, Berrong, M, Garcia, A, Schuetz, A, Cox, J, Frahm, N, Manak, M, Sarzotti-Kelsoe, M, D'Souza, MP, Denny, T, and Ferrari, G. "The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay." Journal of immunological methods 409 (July 2014): 31-43. Full Text Open Access Copy
  - Sarzotti-Kelsoe, M, Needham, LK, Rountree, W, Bainbridge, J, Gray, CM, Fiscus, SA, Ferrari, G, Stevens, WS, Stager, SL, Binz, W, Louzao, R, Long, KO, Mokgotho, P, Moodley, N, Mackay, M, Kerkau, M, McMillion, T, Kirchherr, J, Soderberg, KA, Haynes, BF, and Denny, TN. "The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells." Journal of immunological methods 409 (July 2014): 21-30. Full Text Open Access Copy
  - Moody, MA, Santra, S, Vandergrift, NA, Sutherland, LL, Gurley, TC, Drinker, MS, Allen, AA, Xia, S-M, Meyerhoff, RR, Parks, R, Lloyd, KE, Easterhoff, D, Alam, SM, Liao, H-X, Ward, BM, Ferrari, G, Montefiori, DC, Tomaras, GD, Seder, RA, Letvin, NL, and Haynes, BF. "Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques." Journal of Virology 88, no. 6 (March 2014): 3329-3339. Full Text
  - Veillette, M, Désormeaux, A, Medjahed, H, Gharsallah, N-E, Coutu, M, Baalwa, J, Guan, Y, Lewis, G, Ferrari, G, Hahn, BH, Haynes, BF, Robinson, JE, Kaufmann, DE, Bonsignori, M, Sodroski, J, and Finzi, A. "Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity." Journal of Virology 88, no. 5 (March 2014): 2633-2644. Full Text
  - Yates, NL, Liao, H-X, Fong, Y, deCamp, A, Vandergrift, NA, Williams, WT, Alam, SM, Ferrari, G, Yang, Z-Y, Seaton, KE, Berman, PW, Alpert, MD, Evans, DT, O'Connell, RJ, Francis, D, Sinangil, F, Lee, C, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Tartaglia, J, Pinter, A, Zolla-Pazner, S, Gilbert, PB, Nabel, GJ, Michael, NL, Kim, JH, Montefiori, DC, Haynes, BF, and Tomaras, GD. "Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination." Science Translational Medicine 6, no. 228 (March 2014): 228ra39-null. Full Text
  - Perley, CC, Frahm, M, Click, EM, Dobos, KM, Ferrari, G, Stout, JE, and Frothingham, R. "The human antibody response to the surface of Mycobacterium tuberculosis." Plos One 9, no. 2 (January 2014): e98938-null. Full Text Open Access Copy
  - Roederer, M, Keele, BF, Schmidt, SD, Mason, RD, Welles, HC, Fischer, W, Labranche, C, Foulds, KE, Louder, MK, Yang, Z-Y, Todd, J-PM, Buzby, AP, Mach, LV, Shen, L, Seaton, KE, Ward, BM, Bailer, RT, Gottardo, R, Gu, W, Ferrari, G, Alam, SM, Denny, TN, Montefiori, DC, Tomaras, GD, Korber, BT, Nason, MC, Seder, RA, Koup, RA, Letvin, NL, Rao, SS, Nabel, GJ, and Mascola, JR. "Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV." Nature 505, no. 7484 (January 2014): 502-508. Full Text Open Access Copy
  - Liu, P, Yates, NL, Shen, X, Bonsignori, M, Moody, MA, Liao, H-X, Fong, Y, Alam, SM, Overman, RG, Denny, T, Ferrari, G, Ochsenbauer, C, Kappes, JC, Polonis, VR, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Montefiori, DC, Gilbert, P, Michael, NL, Kim, JH, Haynes, BF, and Tomaras, GD. "Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees." J Virol 87, no. 14 (July 2013): 7828-7836. Full Text Open Access Copy Link to Item
  - Pollara, J, Bonsignori, M, Moody, MA, Pazgier, M, Haynes, BF, and Ferrari, G. "Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses." Curr Hiv Res 11, no. 5 (July 2013): 378-387. (Review) Link to Item
  - Fouda, GGA, Amos, JD, Wilks, AB, Pollara, J, Ray, CA, Chand, A, Kunz, EL, Liebl, BE, Whitaker, K, Carville, A, Smith, S, Colvin, L, Pickup, DJ, Staats, HF, Overman, G, Eutsey-Lloyd, K, Parks, R, Chen, H, Labranche, C, Barnett, S, Tomaras, GD, Ferrari, G, Montefiori, DC, Liao, H-X, Letvin, NL, Haynes, BF, and Permar, SR. "Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk." J Virol 87, no. 12 (June 2013): 6986-6999. Full Text Link to Item
  - Tomaras, GD, Ferrari, G, Shen, X, Alam, SM, Liao, H-X, Pollara, J, Bonsignori, M, Moody, MA, Fong, Y, Chen, X, Poling, B, Nicholson, CO, Zhang, R, Lu, X, Parks, R, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Gilbert, PB, Kim, JH, Michael, NL, Montefiori, DC, and Haynes, BF. "Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG." Proc Natl Acad Sci U S A 110, no. 22 (May 28, 2013): 9019-9024. Full Text Link to Item
  - Vinikoor, MJ, Cope, A, Gay, CL, Ferrari, G, McGee, KS, Kuruc, JD, Lennox, JL, Margolis, DM, Hicks, CB, and Eron, JJ. "Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation." Journal of Acquired Immune Deficiency Syndromes (1999) 62, no. 5 (April 2013): 505-508. Full Text
  - Vaccari, M, Keele, BF, Bosinger, SE, Doster, MN, Ma, Z-M, Pollara, J, Hryniewicz, A, Ferrari, G, Guan, Y, Forthal, DN, Venzon, D, Fenizia, C, Morgan, T, Montefiori, D, Lifson, JD, Miller, CJ, Silvestri, G, Rosati, M, Felber, BK, Pavlakis, GN, Tartaglia, J, and Franchini, G. "Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure." Journal of Virology 87, no. 6 (March 2013): 3538-3548. Full Text
  - Pegu, P, Vaccari, M, Gordon, S, Keele, BF, Doster, M, Guan, Y, Ferrari, G, Pal, R, Ferrari, MG, Whitney, S, Hudacik, L, Billings, E, Rao, M, Montefiori, D, Tomaras, G, Alam, SM, Fenizia, C, Lifson, JD, Stablein, D, Tartaglia, J, Michael, N, Kim, J, Venzon, D, and Franchini, G. "Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial." Journal of Virology 87, no. 3 (February 2013): 1708-1719. Full Text
  - Liao, H-X, Bonsignori, M, Alam, SM, McLellan, JS, Tomaras, GD, Moody, MA, Kozink, DM, Hwang, K-K, Chen, X, Tsao, C-Y, Liu, P, Lu, X, Parks, RJ, Montefiori, DC, Ferrari, G, Pollara, J, Rao, M, Peachman, KK, Santra, S, Letvin, NL, Karasavvas, N, Yang, Z-Y, Dai, K, Pancera, M, Gorman, J, Wiehe, K, Nicely, NI, Rerks-Ngarm, S, Nitayaphan, S, Kaewkungwal, J, Pitisuttithum, P, Tartaglia, J, Sinangil, F, Kim, JH, Michael, NL, Kepler, TB, Kwong, PD, Mascola, JR, Nabel, GJ, Pinter, A, Zolla-Pazner, S, and Haynes, BF. "Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2." Immunity 38, no. 1 (January 24, 2013): 176-186. Full Text Link to Item
  - Lambotte, O, Pollara, J, Boufassa, F, Moog, C, Venet, A, Haynes, BF, Delfraissy, JF, Saez-Cirion, A, and Ferrari, G. "High Antibody-Dependent Cellular Cytotoxicity Responses Are Correlated with Strong CD8 T Cell Viral Suppressive Activity but Not with B57 Status in HIV-1 Elite Controllers." Plos One 8, no. 9 (2013). Full Text
  - Liu, MKP, Hawkins, N, Ritchie, AJ, Ganusov, VV, Whale, V, Brackenridge, S, Li, H, Pavlicek, JW, Cai, F, Rose-Abrahams, M, Treurnicht, F, Hraber, P, Riou, C, Gray, C, Ferrari, G, Tanner, R, Ping, L-H, Anderson, JA, Swanstrom, R, Chavi, CB, Cohen, M, Karim, SSA, Haynes, B, Borrow, P, Perelson, AS, Shaw, GM, Hahn, BH, Williamson, C, Korber, BT, Gao, F, Self, S, McMichael, A, and Goonetilleke, N. "Vertical T cell immunodominance and epitope entropy determine HIV-1 escape." Journal of Clinical Investigation 123, no. 1 (January 2013): 380-393. Full Text Link to Item
  - McKellar, MS, Cope, AB, Gay, CL, McGee, KS, Kuruc, JD, Kerkau, MG, Hurt, CB, Fiscus, SA, Ferrari, G, Margolis, DM, Eron, JJ, Hicks, CB, and Duke-Unc Acute HIV Infection Consortium, . "Acute HIV-1 infection in the Southeastern United States: a cohort study." Aids Research and Human Retroviruses 29, no. 1 (January 2013): 121-128. Full Text
  - Weaver, EA, Nehete, PN, Nehete, BP, Yang, G, Buchl, SJ, Hanley, PW, Palmer, D, Montefiori, DC, Ferrari, G, Ng, P, Sastry, KJ, and Barry, MA. "Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. (Published online)" PLoS One 8, no. 7 (2013): e67574-. Full Text Link to Item
  - Bonsignori, M, Pollara, J, Moody, MA, Alpert, MD, Chen, X, Hwang, K-K, Gilbert, PB, Huang, Y, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Tsao, C-Y, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, JH, Michael, NL, Tomaras, GD, Montefiori, DC, Lewis, GK, DeVico, A, Evans, DT, Ferrari, G, Liao, H-X, and Haynes, BF. "Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family." J Virol 86, no. 21 (November 2012): 11521-11532. Full Text Link to Item
  - Fukazawa, Y, Park, H, Cameron, MJ, Lefebvre, F, Lum, R, Coombes, N, Mahyari, E, Hagen, SI, Bae, JY, Reyes, MD, Swanson, T, Legasse, AW, Sylwester, A, Hansen, SG, Smith, AT, Stafova, P, Shoemaker, R, Li, Y, Oswald, K, Axthelm, MK, McDermott, A, Ferrari, G, Montefiori, DC, Edlefsen, PT, Piatak, M, Lifson, JD, Sékaly, RP, and Picker, LJ. "Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines." Nature Medicine 18, no. 11 (November 2012): 1673-1681. Full Text
  - Song, H, Pavlicek, JW, Cai, F, Bhattacharya, T, Li, H, Iyer, SS, Bar, KJ, Decker, JM, Goonetilleke, N, Liu, MKP, Berg, A, Hora, B, Drinker, MS, Eudailey, J, Pickeral, J, Moody, MA, Ferrari, G, McMichael, A, Perelson, AS, Shaw, GM, Hahn, BH, Haynes, BF, and Gao, F. "Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome.(Published online)" Retrovirology 9 (October 30, 2012): 89-null. Full Text Link to Item
  - Arnoczy, GS, Ferrari, G, Goonetilleke, N, Corrah, T, Li, H, Kuruc, J, Schmitz, JL, McGee, K, Hicks, C, Eron, JJ, and Center for HIV/AIDS Vaccine Immunology AI067854, . "Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation." Aids Research and Human Retroviruses 28, no. 8 (August 2012): 789-792. Full Text
  - Britten, CM, Janetzki, S, Butterfield, LH, Ferrari, G, Gouttefangeas, C, Huber, C, Kalos, M, Levitsky, HI, Maecker, HT, Melief, CJM, O'Donnell-Tormey, J, Odunsi, K, Old, LJ, Ottenhoff, THM, Ottensmeier, C, Pawelec, G, Roederer, M, Roep, BO, Romero, P, van der Burg, SH, Walter, S, Hoos, A, and Davis, MM. "T cell assays and MIATA: the essential minimum for maximum impact." Immunity 37, no. 1 (July 2012): 1-2. (Letter) Full Text
  - Moody, MA, Yates, NL, Amos, JD, Drinker, MS, Eudailey, JA, Gurley, TC, Marshall, DJ, Whitesides, JF, Chen, X, Foulger, A, Yu, J-S, Zhang, R, Meyerhoff, RR, Parks, R, Scull, JC, Wang, L, Vandergrift, NA, Pickeral, J, Pollara, J, Kelsoe, G, Alam, SM, Ferrari, G, Montefiori, DC, Voss, G, Liao, H-X, Tomaras, GD, and Haynes, BF. "HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages." J Virol 86, no. 14 (July 2012): 7496-7507. Full Text Link to Item
  - Freel, SA, Picking, RA, Ferrari, G, Ding, H, Ochsenbauer, C, Kappes, JC, Kirchherr, JL, Soderberg, KA, Weinhold, KJ, Cunningham, CK, Denny, TN, Crump, JA, Cohen, MS, McMichael, AJ, Haynes, BF, and Tomaras, GD. "Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication." J Virol 86, no. 12 (June 2012): 6835-6846. Full Text Open Access Copy Link to Item
  - Frahm, MA, Picking, RA, Kuruc, JD, McGee, KS, Gay, CL, Eron, JJ, Hicks, CB, Tomaras, GD, and Ferrari, G. "CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection." J Immunol 188, no. 9 (May 1, 2012): 4289-4296. Full Text Link to Item
  - Moiani, A, Paleari, Y, Sartori, D, Mezzadra, R, Miccio, A, Cattoglio, C, Cocchiarella, F, Lidonnici, MR, Ferrari, G, and Mavilio, F. "Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts." The Journal of Clinical Investigation 122, no. 5 (May 2012): 1653-1666. Full Text
  - Haynes, BF, Gilbert, PB, McElrath, MJ, Zolla-Pazner, S, Tomaras, GD, Alam, SM, Evans, DT, Montefiori, DC, Karnasuta, C, Sutthent, R, Liao, H-X, DeVico, AL, Lewis, GK, Williams, C, Pinter, A, Fong, Y, Janes, H, DeCamp, A, Huang, Y, Rao, M, Billings, E, Karasavvas, N, Robb, ML, Ngauy, V, de Souza, MS, Paris, R, Ferrari, G, Bailer, RT, Soderberg, KA, Andrews, C, Berman, PW, Frahm, N, De Rosa, SC, Alpert, MD, Yates, NL, Shen, X, Koup, RA, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Michael, NL, and Kim, JH. "Immune-correlates analysis of an HIV-1 vaccine efficacy trial." N Engl J Med 366, no. 14 (April 5, 2012): 1275-1286. Full Text Link to Item
  - Riou, C, Ganusov, VV, Campion, S, Mlotshwa, M, Liu, MKP, Whale, VE, Goonetilleke, N, Borrow, P, Ferrari, G, Betts, MR, Haynes, BF, McMichael, AJ, and Gray, CM. "Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection." J Immunol 188, no. 5 (March 1, 2012): 2198-2206. Full Text Link to Item
  - Lai, L, Kwa, S-F, Kozlowski, PA, Montefiori, DC, Nolen, TL, Hudgens, MG, Johnson, WE, Ferrari, G, Hirsch, VM, Felber, BK, Pavlakis, GN, Earl, PL, Moss, B, Amara, RR, and Robinson, HL. "SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses." Vaccine 30, no. 9 (February 2012): 1737-1745. Full Text
  - Barouch, DH, Liu, J, Li, H, Maxfield, LF, Abbink, P, Lynch, DM, Iampietro, MJ, SanMiguel, A, Seaman, MS, Ferrari, G, Forthal, DN, Ourmanov, I, Hirsch, VM, Carville, A, Mansfield, KG, Stablein, D, Pau, MG, Schuitemaker, H, Sadoff, JC, Billings, EA, Rao, M, Robb, ML, Kim, JH, Marovich, MA, Goudsmit, J, and Michael, NL. "Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys." Nature 482, no. 7383 (January 4, 2012): 89-93. Full Text
  - Cox, JH, Ferrari, MG, Earl, P, Lane, JR, Jagodzinski, LL, Polonis, VR, Kuta, EG, Boyer, JD, Ratto-Kim, S, Eller, L-A, Pham, D-T, Hart, L, Montefiori, D, Ferrari, G, Parrish, S, Weiner, DB, Moss, B, Kim, JH, Birx, D, and VanCott, TC. "Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge." Vaccine 30, no. 10 (2012): 1830-1840. Full Text
  - Friedman, J, Alam, SM, Shen, X, Xia, S-M, Stewart, S, Anasti, K, Pollara, J, Fouda, GG, Yang, G, Kelsoe, G, Ferrari, G, Tomaras, GD, Haynes, BF, Liao, H-X, Moody, MA, and Permar, SR. "Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum." Plos One 7, no. 5 (2012): e37648-null. Full Text Open Access Copy Link to Item
  - Ganusov, VV, Goonetilleke, N, Liu, MKP, Ferrari, G, Shaw, GM, McMichael, AJ, Borrow, P, Korber, BT, and Perelson, AS. "Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection." Journal of Virology 85, no. 20 (October 2011): 10518-10528. Full Text
  - Fouda, GG, Yates, NL, Pollara, J, Shen, X, Overman, GR, Mahlokozera, T, Wilks, AB, Kang, HH, Salazar-Gonzalez, JF, Salazar, MG, Kalilani, L, Meshnick, SR, Hahn, BH, Shaw, GM, Lovingood, RV, Denny, TN, Haynes, B, Letvin, NL, Ferrari, G, Montefiori, DC, Tomaras, GD, Permar, SR, and Center for HIV/AIDS Vaccine Immunology, . "HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies." Journal of Virology 85, no. 18 (September 2011): 9555-9567. Full Text Open Access Copy
  - Pollara, J, Hart, L, Brewer, F, Pickeral, J, Packard, BZ, Hoxie, JA, Komoriya, A, Ochsenbauer, C, Kappes, JC, Roederer, M, Huang, Y, Weinhold, KJ, Tomaras, GD, Haynes, BF, Montefiori, DC, and Ferrari, G. "High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses." Cytometry A 79, no. 8 (August 2011): 603-612. Full Text Link to Item
  - Ferrari, G, Pollara, J, Kozink, D, Harms, T, Drinker, M, Freel, S, Moody, MA, Alam, SM, Tomaras, GD, Ochsenbauer, C, Kappes, JC, Shaw, GM, Hoxie, JA, Robinson, JE, and Haynes, BF. "An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum." J Virol 85, no. 14 (July 2011): 7029-7036. Full Text Link to Item
  - Lai, L, Kwa, S, Kozlowski, PA, Montefiori, DC, Ferrari, G, Johnson, WE, Hirsch, V, Villinger, F, Chennareddi, L, Earl, PL, Moss, B, Amara, RR, and Robinson, HL. "Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine." The Journal of Infectious Diseases 204, no. 1 (July 2011): 164-173. Full Text
  - Frahm, M, Goswami, ND, Owzar, K, Hecker, E, Mosher, A, Cadogan, E, Nahid, P, Ferrari, G, and Stout, JE. "Discriminating between latent and active tuberculosis with multiple biomarker responses." Tuberculosis (Edinburgh, Scotland) 91, no. 3 (May 2011): 250-256. Full Text
  - Yamamoto, T, Price, DA, Casazza, JP, Ferrari, G, Nason, M, Chattopadhyay, PK, Roederer, M, Gostick, E, Katsikis, PD, Douek, DC, Haubrich, R, Petrovas, C, and Koup, RA. "Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection." Blood 117, no. 18 (May 2011): 4805-4815. Full Text
  - Ganusov, V, Goonetilleke, N, Liu, M, Ferrari, G, Shaw, G, McMichael, A, Borrow, P, Korber, B, and Perelson, A. "Fitness costs and diversity of CTL response determine the rate of CTL escape during the acute and chronic phases of HIV infection." JOURNAL OF IMMUNOLOGY 186 (April 2011). Link to Item
  - Gay, CL, Mayo, AJ, Mfalila, CK, Chu, H, Barry, AC, Kuruc, JD, McGee, KS, Kerkau, M, Sebastian, J, Fiscus, SA, Margolis, DM, Hicks, CB, Ferrari, G, Eron, JJ, and Duke-UNC Acute HIV Infection Consortium, . "Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection." Aids (London, England) 25, no. 7 (April 2011): 941-949. Full Text
  - Ferrari, G, Korber, B, Goonetilleke, N, Liu, MKP, Turnbull, EL, Salazar-Gonzalez, JF, Hawkins, N, Self, S, Watson, S, Betts, MR, Gay, C, McGhee, K, Pellegrino, P, Williams, I, Tomaras, GD, Haynes, BF, Gray, CM, Borrow, P, Roederer, M, McMichael, AJ, and Weinhold, KJ. "Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.(Published online)" Plos Pathog 7, no. 2 (February 10, 2011): e1001273-null. Full Text Link to Item
  - Keefer, MC, Frey, SE, Elizaga, M, Metch, B, De Rosa, SC, Barroso, PF, Tomaras, G, Cardinali, M, Goepfert, P, Kalichman, A, Philippon, V, McElrath, MJ, Jin, X, Ferrari, G, Defawe, OD, Mazzara, GP, Montefiori, D, Pensiero, M, Panicali, DL, Corey, L, and NIAID HIV Vaccine Trials Network, . "A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects." Vaccine 29, no. 10 (February 2011): 1948-1958. Full Text
  - Gay, C, Dibben, O, Anderson, JA, Stacey, A, Mayo, AJ, Norris, PJ, Kuruc, JD, Salazar-Gonzalez, JF, Li, H, Keele, BF, Hicks, C, Margolis, D, Ferrari, G, Haynes, B, Swanstrom, R, Shaw, GM, Hahn, BH, Eron, JJ, Borrow, P, and Cohen, MS. "Cross-sectional detection of acute HIV infection: Timing of transmission, inflammation and antiretroviral therapy." PLoS ONE 6, no. 5 (2011). Full Text
  - Graham, BS, McElrath, MJ, Keefer, MC, Rybczyk, K, Berger, D, Weinhold, KJ, Ottinger, J, Ferarri, G, Montefiori, DC, Stablein, D, Smith, C, Ginsberg, R, Eldridge, J, Duerr, A, Fast, P, Haynes, BF, and AIDS Vaccine Evaluation Group, . "Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity. (Published online)" PLoS One 5, no. 8 (August 10, 2010): e11995-. Full Text Open Access Copy Link to Item
  - Freel, SA, Lamoreaux, L, Chattopadhyay, PK, Saunders, K, Zarkowsky, D, Overman, RG, Ochsenbauer, C, Edmonds, TG, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Haynes, BF, Koup, RA, Graham, BS, Roederer, M, and Tomaras, GD. "Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination." Journal of Virology 84, no. 10 (May 2010): 4998-5006. Full Text
  - Cella, M, Presti, R, Vermi, W, Lavender, K, Turnbull, E, Ochsenbauer-Jambor, C, Kappes, JC, Ferrari, G, Kessels, L, Williams, I, CHAVI Clinical Core B, , McMichael, AJ, Haynes, BF, Borrow, P, Colonna, M, and NIAID Center for HIV/AIDS Vaccine Immunology, . "Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection." Eur J Immunol 40, no. 4 (April 2010): 949-954. Full Text Link to Item
  - Janetzki, S, Price, L, Britten, CM, van der Burg, SH, Caterini, J, Currier, JR, Ferrari, G, Gouttefangeas, C, Hayes, P, Kaempgen, E, Lennerz, V, Nihlmark, K, Souza, V, and Hoos, A. "Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells." Cancer Immunology, Immunotherapy : Cii 59, no. 4 (April 2010): 609-618. Full Text
  - Makedonas, G, Hutnick, N, Haney, D, Amick, AC, Gardner, J, Cosma, G, Hersperger, AR, Dolfi, D, Wherry, EJ, Ferrari, G, and Betts, MR. "Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells." Plos Pathogens 6, no. 3 (March 5, 2010): e1000798-null. Full Text Open Access Copy
  - Weinberg, A, Song, LY, Wilkening, CL, Fenton, T, Hural, J, Louzao, R, Ferrari, G, Etter, PE, Berrong, M, Canniff, JD, Carter, D, Defawe, OD, Garcia, A, Garrelts, TL, Gelman, R, Lambrecht, LK, Pahwa, S, Pilakka-Kanthikeel, S, Shugarts, DL, and Tustin, NB. "Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays." Journal of Immunological Methods 363, no. 1 (2010): 42-50. Full Text
  - Goonetilleke, N, Liu, MKP, Salazar-Gonzalez, JF, Ferrari, G, Giorgi, E, Ganusov, VV, Keele, BF, Learn, GH, Turnbull, EL, Salazar, MG, Weinhold, KJ, Moore, S, CHAVI Clinical Core B, , Letvin, N, Haynes, BF, Cohen, MS, Hraber, P, Bhattacharya, T, Borrow, P, Perelson, AS, Hahn, BH, Shaw, GM, Korber, BT, and McMichael, AJ. "The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection." The Journal of Experimental Medicine 206, no. 6 (June 2009): 1253-1272. Full Text
  - Wood, N, Bhattacharya, T, Keele, BF, Giorgi, E, Liu, M, Gaschen, B, Daniels, M, Ferrari, G, Haynes, BF, McMichael, A, Shaw, GM, Hahn, BH, Korber, B, and Seoighe, C. "HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC." Plos Pathogens 5, no. 5 (May 8, 2009): e1000414-null. Full Text
  - Lambotte, O, Ferrari, G, Moog, C, Yates, NL, Liao, H-X, Parks, RJ, Hicks, CB, Owzar, K, Tomaras, GD, Montefiori, DC, Haynes, BF, and Delfraissy, J-F. "Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers." Aids (London, England) 23, no. 8 (May 2009): 897-906. Full Text
  - Spearman, P, Kalams, S, Elizaga, M, Metch, B, Chiu, Y-L, Allen, M, Weinhold, KJ, Ferrari, G, Parker, SD, McElrath, MJ, Frey, SE, Fuchs, JD, Keefer, MC, Lubeck, MD, Egan, M, Braun, R, Eldridge, JH, Haynes, BF, Corey, L, and NIAID HIV Vaccine Trials Network, . "Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial." Vaccine 27, no. 2 (January 2009): 243-249. Full Text
  - Gasper-Smith, N, Crossman, DM, Whitesides, JF, Mensali, N, Ottinger, JS, Plonk, SG, Moody, MA, Ferrari, G, Weinhold, KJ, Miller, SE, Reich, CF, Qin, L, Self, SG, Shaw, GM, Denny, TN, Jones, LE, Pisetsky, DS, and Haynes, BF. "Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design." Journal of Virology 82, no. 15 (August 2008): 7700-7710. Full Text
  - Dagenais, GR, Gerstein, HC, Holman, R, Budaj, A, Escalante, A, Hedner, T, Keltai, M, Lonn, E, McFarlane, S, McQueen, M, Teo, K, Sheridan, P, Bosch, J, Pogue, J, and Yusuf, S. "Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial." Diabetes Care 31, no. 5 (May 2008): 1007-1014. Full Text
  - Gorse, GJ, Baden, LR, Wecker, M, Newman, MJ, Ferrari, G, Weinhold, KJ, Livingston, BD, Villafana, TL, Li, H, Noonan, E, Russell, ND, and HIV Vaccine Trials Network, . "Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults." Vaccine 26, no. 2 (January 2008): 215-223. Full Text
  - Hicks, CB, Gay, C, and Ferrari, G. "Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses." Clin Exp Immunol 149, no. 2 (August 2007): 211-216. (Review) Full Text Link to Item
  - Montefiori, DC, Morris, L, Ferrari, G, and Mascola, JR. "Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination." Current Opinion in Hiv and Aids 2, no. 3 (May 2007): 169-176. Full Text
  - Russell, ND, Graham, BS, Keefer, MC, McElrath, MJ, Self, SG, Weinhold, KJ, Montefiori, DC, Ferrari, G, Horton, H, Tomaras, GD, Gurunathan, S, Baglyos, L, Frey, SE, Mulligan, MJ, Harro, CD, Buchbinder, SP, Baden, LR, Blattner, WA, Koblin, BA, Corey, L, and National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network, . "Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial." Journal of Acquired Immune Deficiency Syndromes (1999) 44, no. 2 (February 2007): 203-212. Full Text
  - Goepfert, PA, Tomaras, GD, Horton, H, Montefiori, D, Ferrari, G, Deers, M, Voss, G, Koutsoukos, M, Pedneault, L, Vandepapeliere, P, McElrath, MJ, Spearman, P, Fuchs, JD, Koblin, BA, Blattner, WA, Frey, S, Baden, LR, Harro, C, Evans, T, and NIAID HIV Vaccine Trials Network, . "Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers." Vaccine 25, no. 3 (January 2007): 510-518. Full Text
  - Bosch, J, Yusuf, S, Gerstein, HC, Pogue, J, Sheridan, P, Dagenais, G, Chiasson, JL, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, RR, Anand, S, Budaj, A, Conget, I, Davis, M, Dinccag, N, Enjalbert, M, Escalante, A, Hanefeld, M, Hedner, T, Jolly, K, Keltai, M, Laakso, M, Lonn, E, McQueen, M, Mohan, V, Phillips, A, Piegas, L, Pirags, V, Schmid, I, Shaw, J, Teo, K, Zimmet, P, Zinman, B, Ahuad Guerrero, R, Albisu, J, Alvarez, MS, Arregui, V, Avaca, H, Baglivo, H, Balbuena, M, Bello, F, Bono, J, Botto, M, Brandani, L, Brandes, M, Bruera, D, Cabral Venere, R, Caccavo, A, Cacurri, A, Caime, G, Capozzi, M, Carrique, A, Carrique, P, Cartasegna, L, Casabe, J, Casaccia, G, Castellanos, C, Castro, L, Cendali, G, Cerchi, P, Cerdan, M, Cinalli, M, Cipullo, M, Cismondi, M, Citta, N, Citta, L, Crespo, C, Crunger, P, Cuneo, C, De Loredo, L, De Loredo, S, Del Cerro, S, Denaro, R, Esperatti, E, Esposito, L, Farras, H, Fernandez, S, Fernandez, M, Fernandez, A, Ferrari, G, Focaccia, M, Frontini, L, Gabito, A, Gambarte, A, Garrido, M, and Garrido, I. "Effect of ramipril on the incidence of diabetes." New England Journal of Medicine 355, no. 15 (October 12, 2006): 1551-1562. Full Text
  - Mulligan, MJ, Russell, ND, Celum, C, Kahn, J, Noonan, E, Montefiori, DC, Ferrari, G, Weinhold, KJ, Smith, JM, Amara, RR, Robinson, HL, and NIH/NIAID/DAIDS HIV Vaccine Trials Network, . "Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults." Aids Research and Human Retroviruses 22, no. 7 (July 2006): 678-683. Full Text
  - Betts, MR, Gray, CM, Cox, JH, and Ferrari, G. "Antigen-specific T-cell-mediated immunity after HIV-1 infection: Implications for vaccine control of HIV development." Expert Review of Vaccines 5, no. 4 (2006): 505-516. Full Text
  - Cox, JH, Ferrari, G, and Janetzki, S. "Measurement of cytokine release at the single cell level using the ELISPOT assay." Methods 38, no. 4 (2006): 274-282. Full Text
  - Goepfert, PA, Horton, H, McElrath, MJ, Gurunathan, S, Ferrari, G, Tomaras, GD, Montefiori, DC, Allen, M, Chiu, Y-L, Spearman, P, Fuchs, JD, Koblin, BA, Blattner, WA, Frey, S, Keefer, MC, Baden, LR, Corey, L, and NIAID HIV Vaccine Trials Network, . "High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects." The Journal of Infectious Diseases 192, no. 7 (October 2005): 1249-1259. Full Text
  - Sempowski, GD, Hicks, CB, Eron, JJ, Bartlett, JA, Hale, LP, Ferrari, G, Edwards, LJ, Fiscus, S, and Haynes, BF. "Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function." Journal of Clinical Immunology 25, no. 5 (September 2005): 462-472. Full Text
  - Betts, MR, Exley, B, Price, DA, Bansal, A, Camacho, ZT, Teaberry, V, West, SM, Ambrozak, DR, Tomaras, G, Roederer, M, Kilby, JM, Tartaglia, J, Belshe, R, Gao, F, Douek, DC, Weinhold, KJ, Koup, RA, Goepfert, P, and Ferrari, G. "Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection." Proceedings of the National Academy of Sciences of the United States of America 102, no. 12 (March 7, 2005): 4512-4517. Full Text
  - Currier, JR, Harris, ME, Cox, JH, McCutchan, FE, Birx, DL, Maayan, S, and Ferrari, G. "Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians." Aids Research and Human Retroviruses 21, no. 3 (March 2005): 239-245. Full Text
  - Cox, JH, Ferrari, G, Kalams, SA, Lopaczynski, W, Oden, N, D'souza, MP, and Elispot Collaborative Study Group, . "Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials." Aids Research and Human Retroviruses 21, no. 1 (January 2005): 68-81. Full Text
  - Janetzki, S, Cox, JH, Oden, N, and Ferrari, G. "Standardization and validation issues of the ELISPOT assay." Methods in molecular biology (Clifton, N.J.) 302 (2005): 51-86.
  - Kaplan, SS, Ferrari, G, Wrin, T, Hellmann, NS, Tomaras, GD, Gryszowka, VE, Fiscus, SA, Weinhold, KJ, and Hicks, CB. "Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance." Aids Research and Human Retroviruses 21, no. 1 (January 2005): 13-16. Full Text
  - Ferrari, G, Neal, W, Ottinger, J, Jones, AM, Edwards, BH, Goepfert, P, Betts, MR, Koup, RA, Buchbinder, S, McElrath, MJ, Tartaglia, J, and Weinhold, KJ. "Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele." Journal of Immunology (Baltimore, Md. : 1950) 173, no. 3 (August 2004): 2126-2133. Full Text
  - Ferrari, G, Currier, JR, Harris, ME, Finkelstein, S, de Oliveira, A, Barkhan, D, Cox, JH, Zeira, M, Weinhold, KJ, Reinsmoen, N, McCutchan, F, Birx, DL, Osmanov, S, and Maayan, S. "HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians." Hum Immunol 65, no. 6 (June 2004): 648-659. Full Text Link to Item
  - Cox, JH, Ferrari, G, Bailer, RT, and Koup, RA. "Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells." Journal of Laboratory Automation 9, no. 1 (January 1, 2004): 16-23. Full Text
  - Harris, ME, Maayan, S, Kim, B, Zeira, M, Ferrari, G, Birx, DL, and McCutchan, FE. "A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions." Aids Research and Human Retroviruses 19, no. 12 (December 2003): 1125-1133. Full Text
  - Sufka, SA, Ferrari, G, Gryszowka, VE, Wrin, T, Fiscus, SA, Tomaras, GD, Staats, HF, Patel, DD, Sempowski, GD, Hellmann, NS, Weinhold, KJ, and Hicks, CB. "Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control." The Journal of Infectious Diseases 187, no. 7 (April 2003): 1027-1037. Full Text
  - Currier, JR, Kuta, EG, Turk, E, Earhart, LB, Loomis-Price, L, Janetzki, S, Ferrari, G, Birx, DL, and Cox, JH. "A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays." Journal of Immunological Methods 260, no. 1-2 (February 2002): 157-172. Full Text
  - Ferrari, G, Neal, W, Jones, A, Olender, N, Ottinger, J, Ha, R, McElrath, MJ, Goepfert, P, and Weinhold, KJ. "CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition." Immunol Lett 79, no. 1-2 (November 1, 2001): 37-45. Link to Item
  - Ferrari, G, Kostyu, DD, Cox, J, Dawson, DV, Flores, J, Weinhold, KJ, and Osmanov, S. "Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines." Aids Research and Human Retroviruses 16, no. 14 (September 2000): 1433-1443. (Review) Full Text
  - Markert, ML, Hicks, CB, Bartlett, JA, Harmon, JL, Hale, LP, Greenberg, ML, Ferrari, G, Ottinger, J, Boeck, A, Kloster, AL, McLaughlin, TM, Bleich, KB, Ungerleider, RM, Lyerly, HK, Wilkinson, WE, Rousseau, FS, Heath-Chiozzi, ME, Leonard, JM, Haase, AT, Shaw, GM, Bucy, RP, Douek, DC, Koup, RA, Haynes, BF, Bolognesi, DP, and Weinhold, KJ. "Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection." Aids Research and Human Retroviruses 16, no. 5 (March 2000): 403-413. Full Text
  - Tomaras, GD, Lacey, SF, McDanal, CB, Ferrari, G, Weinhold, KJ, and Greenberg, ML. "CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression." Proceedings of the National Academy of Sciences of the United States of America 97, no. 7 (March 2000): 3503-3508. Full Text
  - Falk, LA, Goldenthal, KL, Esparza, J, Aguado, MT, Osmanov, S, and Ballou, WR. "Recombinant Bacillus Calmette-Guerin as a Potential Vector for Preventive HIV Type 1 Vaccines." Aids Research and Human Retroviruses 16, no. 2 (January 20, 2000): 91-98. Full Text
  - Stranford, SA, Skurnick, J, Louria, D, Osmond, D, Chang, S-Y, Sninsky, J, Ferrari, G, Weinhold, K, Lindquist, C, and Levy, JA. "Lack of infection in HIV-exposed individuals is associated with a strong CD8⁺ cell noncytotoxic anti-HIV response." Proceedings of the National Academy of Sciences of the United States of America 96, no. 3 (1999): 1030-1035. Full Text
  - Ferrari, G, Berend, C, Ottinger, J, Dodge, R, Bartlett, J, Toso, J, Moody, D, Tartaglia, J, Cox, WI, Paoletti, E, and Weinhold, KJ. "Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy." Blood 90, no. 6 (September 1997): 2406-2416.
  - Ferrari, G, Humphrey, W, McElrath, MJ, Excler, JL, Duliege, AM, Clements, ML, Corey, LC, Bolognesi, DP, and Weinhold, KJ. "Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers." Proceedings of the National Academy of Sciences of the United States of America 94, no. 4 (February 1997): 1396-1401. Full Text
  - Toso, JF, Chen, CH, Mohr, JR, Piglia, L, Oei, C, Ferrari, G, Greenberg, ML, and Weinhold, KJ. "Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication." The Journal of Infectious Diseases 172, no. 4 (October 1995): 964-973. Full Text
  - Ferrari, G, King, K, Rathbun, K, Place, CA, Packard, MV, Bartlett, JA, Bolognesi, DP, and Weinhold, KJ. "IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp)." Clinical and Experimental Immunology 101, no. 2 (August 1995): 239-248. Full Text
  - Ferrari, G, Place, CA, Ahearne, PM, Nigida, SM, Arthur, LO, Bolognesi, DP, and Weinhold, KJ. "Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees." Journal of Acquired Immune Deficiency Syndromes 7, no. 4 (April 1994): 325-331.
  - Ferrari, G, Ottinger, J, Place, C, Nigida, SM, Arthur, LO, and Weinhold, KJ. "The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees." AIDS Res Hum Retroviruses 9, no. 7 (July 1993): 647-656. Full Text Link to Item
  - BOERI, E, GIRI, A, LILLO, F, FERRARI, G, VARNIER, OE, FERRO, A, SABBATANI, S, SAXINGER, WC, and FRANCHINI, G. "INVIVO GENETIC-VARIABILITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 V3-REGION." Journal of Virology 66, no. 7 (July 1, 1992): 4546-4550. (Academic Article) Link to Item
  - Boeri, E, Giri, A, Lillo, F, Ferrari, G, Varnier, OE, Ferro, A, Sabbatani, S, Saxinger, WC, and Franchini, G. "In vivo genetic variability of the human immunodeficiency virus type 2 V3 region." Journal of Virology 66, no. 7 (July 1992): 4546-4550.
  - CANESSA, A, PANTAROTTO, F, MILETICH, F, RUSSO, A, GOTTA, C, BOZZUFFI, PM, FERRARI, G, FIORELLI, A, and TERRAGNA, A. "ANTIBODY PREVALENCE TO TORCH AGENTS IN PREGNANT-WOMEN AND RELATIVE RISK OF CONGENITAL INFECTIONS IN ITALY (LIGURIA)." Biological Research in Pregnancy and Perinatology 8, no. 2 (January 1, 1987): 84-88. (Academic Article) Link to Item
  - Canessa, A, Pantarotto, F, Miletich, F, Russo, A, Gotta, C, Bozzuffi, PM, Ferrari, G, Fiorelli, A, and Terragna, A. "Antibody prevalence to torch agents in pregnant women and relative risk of congenital infections in Italy (Liguria)." Biological Research in Pregnancy and Perinatology 8, no. 2 (1987): 84-88.
  - Mimano, LN, Ferrari, G, Kapanda, G, Lisasi, E, Kulanga, A, Nyombi, B, Muiruri, C, Kessi, E, Bartlett, J, and Ntabaye, M. "Student perceptions on the introduction of training in diagnostic laboratory techniques in an African school of medicine(Published online)." Mededpublish . Full Text
- Book Sections
  - D'Souza, P, Cox, JH, Ferrari, G, Kunwar, NT, Polonis, V, and Sarzotti-Kelsoe, M. "Endpoint Assays in HIV-1 Vaccine Trials: Functioning in a Good Laboratory Practices Environment." In Validation of Cell-Based Assays in the GLP Setting: A Practical Guide, 239-275. April 8, 2008. Full Text
- Other Articles
  - Kvistborg, P, Gouttefangeas, C, Aghaeepour, N, Cazaly, A, Chattopadhyay, PK, Chan, C, Eckl, J, Finak, G, Hadrup, SR, Maecker, HT, Maurer, D, Mosmann, T, Qiu, P, Scheuermann, RH, Welters, MJP, Ferrari, G, Brinkman, RR, and Britten, CM. "Thinking outside the gate: single-cell assessments in multiple dimensions." Immunity 42, no. 4 (April 2015): 591-592. (Letter) Full Text
  - Frahm, MA, Tomaras, GD, and Ferrari, G. "Response to comment on "CD4 ⁺CD8 ⁺ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection"." Journal of Immunology 188, no. 12 (June 15, 2012): 5809-5810. (Letter) Full Text
  - Barre-Sinoussi, F, Berkley, S, Bhamarapravati, N, Birx, D, Bloom, B, Carvalheiro, J, Ganguly, N, Johnston, M, Kazatchkine, M, Makgoba, WM, Monico, SM, Nathanson, N, Schild, G, Wigzell, H, Yamasaki, S, Aubertin, A-M, Bartos, M, Bermann, P, Bradac, J, Burke, D, Cao, H, Desrosiers, R, Ensoli, B, Fenyö, EM, Ferrari, G, Galvao-Castro, B, Godal, T, Goudsmit, J, Frachette, M-J, Ginsberg, R, Heeney, J, Holmes, H, Jin, X, Kalish, M, Klein, M, Korber, B, Liu, M, McMichael, A, McCutchan, F, and Mhalu, F et al. "Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1." AIDS 15, no. 6 (2001): W1-W25. Full Text
  - Rodenburg, CM, Li, Y, Trask, SA, Chen, Y, Decker, J, Robertson, DL, Kalish, ML, Shaw, GM, Allen, S, Hahn, BH, Gao, F, and UNAIDS and NIAID Networks for HIV Isolation and Characterization, . "Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents." Aids Research and Human Retroviruses 17, no. 2 (January 2001): 161-168. Full Text
- Conference Papers
  - Asbach, B, Kibler, KV, Köstler, J, Perdiguero, B, Yates, NL, Stanfield-Oakley, S, Tomaras, GD, Kao, S-F, Foulds, KE, Roederer, M, Seaman, MS, Montefiori, DC, Parks, R, Ferrari, G, Forthal, DN, Phogat, S, Tartaglia, J, Barnett, SW, Self, SG, Gottardo, R, Cristillo, AD, Weiss, DE, Galmin, L, Ding, S, Heeney, JL, Esteban, M, Jacobs, BL, Pantaleo, G, and Wagner, R. "Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost." February 2019. Full Text
  - Felber, B, Singh, S, Valentin, A, Rosati, M, Ramierz, E, Doueiri, R, Hu, X, Bear, J, Hirsch, V, Broderick, K, Sardesai, N, Reed, S, Trinh, H, Rao, M, Montefiori, D, Ferrari, G, Shen, X, Tomaras, G, and Pavlakis, G. "DNA and protein co-delivery vaccines using TLR-4-based adjuvants induce potent immune responses able to delay heterologous SIV acquisition." : WILEY, October 1, 2018. Link to Item
  - Mielke, D, Ziki, R, Anthony, C, Ochsenbauer, C, Garrett, N, Karim, SSA, Montefiori, D, Moore, P, Morris, L, Ferrari, G, and Williamson, C. "Neutralizing and ADCC Activity of Anti-HIV-1 Antibodies Against Acute Subtype C Envs: Implications for Prevention and Treatment of HIV-1 Infection." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Msafiri, F, Joachim, A, Chissumba, RM, Geldmacher, C, Aboud, S, Stohr, W, Viegas, E, Kroidl, A, Munseri, PM, Wahren, B, Sandstrom, E, Robb, ML, McCormack, S, Joseph, S, Jani, I, Ferrari, G, Rao, M, Biberfeld, G, Lyamuya, E, and Nilsson, C. "Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA With or Without CN54rgp140/GLA-AF in Healthy Tanzanian and Mozambican Volunteers." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Phillips, B, Fouda, G, Pollara, J, Kozlowski, P, Moody, A, Ferrari, G, Permar, S, and De Parisi, K. "The optimization of pediatric vaccine regimens to prevent mother-to-child transmission of HIV through breast milk." : WILEY, October 1, 2018. Link to Item
  - Pollara, J, Jones, DI, Huffman, T, Dennis, M, Li, G, Goodman, D, Edwards, RW, Kumar, A, LaBranche, CC, Montefiori, DC, Fouda, GG, Tomaras, GD, Ferrari, G, Staats, HF, and Permar, SR. "Bridging Vaccine-induced Antibody Responses in Rabbit and Rhesus Macaque Animal Models." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Shen, X, Moodie, Z, McMillan, A, Goodman, D, Yates, N, Spreng, R, Grunenberg, N, Gilbert, P, Phogat, S, Diazgranados, C, Laher, F, Bekker, L-G, Gray, G, Corey, L, McElrath, J, Ferrari, G, and Tomaras, G. "V1V2 IgG and Antibody Fc Effector Functions in a Subtype C ALVAC-HIV and Bivalent Subtype C gp120/MF59 HIV-1 Vaccine Trial in South Africa." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Tuyishime, M, Garrido, C, Jha, S, DeVico, A, Haynes, B, Margolis, D, and Ferrari, G. "Recognition and Elimination of HIV-1-infected Cells by ADCC-mediating mAbs for Prevention and Treatment of HIV-1 Infection." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Wang, S, Pollara, J, Stanfield-Oakley, S, Farfan-Arribas, D, Liu, S, Ferrari, G, and Lu, S. "Cross-clade ADCC Activities in Human Volunteer Sera Elicited by a Polyvalent DNA Prime-protein Boost HIV Vaccine DP6-001." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Williams, L, Tay, MZ, Shen, X, Sawant, S, Dahora, L, Yates, N, Easterhoff, D, Robb, M, O'Connell, R, Vasan, S, Rerks-Ngarm, S, Pitisuttithum, P, Nitayaphan, S, deCamp, A, Phogat, S, Sinangil, F, Pollara, J, Haynes, B, Ferrari, G, and Tomaras, G. "Delayed and Repetitive Boosting of RV144 Vaccinees Improves Antiviral Immunity Associated With Correlates of HIV-1 Infection Risk." HIV Research for Prevention Meeting (HIVR4P) - AIDS Vaccine, Microbicide and ARV-Based Prevention Science. Madrid, SPAIN. October 21, 2018 - October 25, 2018.: MARY ANN LIEBERT, INC, October 1, 2018. Link to Item
  - Ferrari, G, Nordstrom, J, Koenig, S, Sung, J, Margolis, D, and Haynes, B. "A-102 Antibody binding to HIV-1 infected cells as mechanism for treatment of HIV infection." : Ovid Technologies (Wolters Kluwer Health), April 2018. Full Text
  - Buchbinder, S, Grunenberg, N, Sanchez, B, Seaton, K, Ferrari, G, Moody, MA, Frahm, N, Montefiori, D, Goepfert, P, Baden, L, Hay, C, Yu, X, Gilbert, P, McElrath, MJ, Huang, Y, Robinson, H, Tomaras, G, and Grp, HVTNS. "DNA/MVA HIV Vaccine Producing Virus-like Particles (VLPs) Is Well-tolerated and Induces Durable Functional Antibodies (Abs) in HVTN 094." October 2016. Link to Item
  - Huang, Y, Tomaras, G, Andersen-Nissen, E, Dintwe, O, Morris, L, Grunenberg, N, Issacs, A, DiazGranados, C, Sinangil, F, Laher, F, Swann, E, DeRosa, S, Ferrari, G, Montefiori, D, Gilbert, P, McElrath, J, Corey, L, Gray, G, and HVTN097, . "The Relationship between Immune Responses to Tetanus Vaccine, Hepatitis B Vaccine and a Pox-protein HIV Vaccine Regimen." October 2016. Link to Item
  - Shen, X, Basu, R, Kwa, S, Labranche, C, Beaumont, D, Ferrari, G, Wyatt, L, Moss, B, Montefiori, D, Tomaras, G, and Robinson, H. "MVA-expressed gp140 Boosts More Durable V1/V2 and gp120 Antibody Responses than gp120 Protein in Alum." October 2016. Link to Item
  - Clutton, GT, Xu, Y, Fernandez, MA, Crooks, A, Turner, B, Maponga, N, Cope, A, Fiscus, S, McGee, K, McKellar, M, Kuruc, J, Ferrari, G, Margolis, D, Hicks, C, Eron, J, Gay, C, and Goonetilleke, N. "Effects of different treatment regimens on T cell function in acute HIV infection." May 1, 2016. Link to Item
  - Prentice, H, Tomaras, G, Geraghty, D, Apps, R, Fong, Y, Ehrenberg, P, Rolland, M, Kijak, G, Nelson, W, Decamp, A, Shen, X, Yates, N, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Pitisuttithum, P, Ferrari, G, Montefiori, D, McElrath, J, Bailer, R, Koup, R, O'Connell, R, Robb, M, Michael, N, Kim, J, and Thomas, R. "HIV-1-specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy." July 2015. Full Text Link to Item
  - Swiderska-Syn, M, Choi, S, Lan, A, Ferrari, G, Diehl, A, and Naggie, S. "P0469 : Markers of tissue repair and cellular aging are increased in liver tissue of patients with dual chronic HIV/HCV infections." April 2015. Full Text
  - Fouda, G, Pollara, J, McGuire, E, Rountree, W, Overman, G, Tegha, G, Kamwendo, D, Kumwenda, J, Nelson, J, Liao, L, Ellington, S, King, C, Jamieson, D, Van der Horst, C, Kourtis, A, Tomaras, G, Ferrari, G, and Permar, S. "Association of HIV-1 Env Antibody Responses with Postnatal Mother-to-Child Transmission of HIV-1 via Breastfeeding." October 2014. Full Text
  - Fourati, S, Vaccari, M, Gordon, SN, Schifanella, L, Cameron, M, Keele, BF, Shen, X, Tomoras, GD, Billings, E, Rao, M, Chung, AW, Dowell, K, Bailey-Kellogg, C, Brown, E, Ackerman, ME, Liyanage, NP, Vargas-Inchaistegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Loré, K, Roederer, M, Koup, RA, McDermott, A, Ma, ZM, Miller, CJ, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Ferrari, G, Thompson, D, Robert-Guroff, M, Ratto-Kim, S, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Alter, G, Sekaly, RP, and Franchini, G. "Modulation of RAS Pathways as a Biomarker of Protection against HIV and as a Means to Improve Vaccine Efficacy." October 2014. Full Text
  - Moody, MA, Easterhoff, D, Gurley, TC, Whitesides, JF, Marshall, DJ, Foulger, A, Lloyd, KE, Parks, R, Pollara, J, Duffy, R, Shen, S, Kim, JH, Michael, NL, Robb, ML, O'Connell, RJ, Vasan, S, Excler, JL, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Nitayaphan, S, Sinangil, F, Francis, D, Lee, C, Kepler, TB, Alam, SM, Ferrari, G, Montefiori, DC, Liao, HX, Tomaras, GD, and Haynes, BF. "Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees." October 2014. Full Text
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Cameron, M, Keele, BF, Shen, X, Tomaras, G, Billings, E, Rao, M, Liyanage, NP, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Lore, K, Roederer, M, Koup, R, McDermott, A, Ma, ZM, Christopher, M, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Ferrari, G, Robert-Guroff, M, Ratto-Kim, S, Kim, J, Michael, N, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Sekaly, RP, and Franchini, G. "Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition." October 2014. Full Text
  - Ackerman, ME, Huang, Y, Alter, G, Ferrari, G, Forthal, D, Kappes, J, Lewis, G, Love, JC, Harris, L, Borate, B, Trujillo, C, Ramsey, S, Woo, S, Greene, K, Gao, H, and Montefiori, D. "Comparative Evaluation of Assays for Fc Receptor-Mediated Antibody Effector Functions Targeting HIV-1." November 1, 2013. Link to Item
  - Blasi, M, Negri, D, Santra, S, Parks, R, Shen, X, Tomaras, G, Permar, S, Montefiori, D, LaBranche, C, Ferrari, G, Alam, M, Liao, H, Moody, AM, Haynes, BF, Klotman, ME, and Cara, A. "A Single Immunization with Integrase Defective Lentiviral Vector Expressing gp140 Induces Persistent and Functional Immune Response in Rhesus Monkeys." Conference on AIDS Vaccine. Barcelona, SPAIN. October 7, 2013 - October 10, 2013.: MARY ANN LIEBERT, INC, November 1, 2013. Link to Item
  - Chege, GK, Montefiori, DC, Barnett, S, Gray, CM, Burgers, WA, Muller, TL, Shephard, EG, Williamson, C, Ferrari, G, and Williamson, A. "A Combined Saavi MVA-C and Novartis Gp140 Env Protein Vaccine Boost Elicits Robust HIV Cellular and Humoral Responses in a Nonhuman Primate Model." Conference on AIDS Vaccine. Barcelona, SPAIN. October 7, 2013 - October 10, 2013.: MARY ANN LIEBERT, INC, November 1, 2013. Link to Item
  - Gao, F, Bonsignori, M, Liao, H, Kumar, A, Xia, S, Cai, F, Lu, X, Kozink, DM, Kwong, P, Zhou, T, Lynch, R, Alam, SM, Ferrari, G, Kelsoe, G, Sandrasegaram, G, Shaw, GM, Hahn, BH, Montefiori, DC, Kamanga, G, Cohen, M, Braber, P, Korber, BT, Mascola, JR, Kepler, TB, and Haynes, BF. "Multiple Pathways of HIV-1 Autologous Neutralizing Antibodies Cooperate to Drive CD4 Binding Site Broadly Neutralizing Antibody Responses." November 1, 2013. Link to Item
  - Gordon, SN, Vaccari, M, Doster, MN, Liyanage, NP, Pegu, P, Schifanella, L, Caccuri, F, Keele, BF, Foulds, KE, Shen, X, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Venzon, D, Stablien, D, Barouch, DH, Felber, BK, Pavlakis, GN, Michael, NL, Tartaglia, J, and Franchini, G. "Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination." November 1, 2013. Link to Item
  - Joachim, A, Munseri, P, Nilsson, C, Bakari, M, Aboud, S, Lyamuya, EF, Moshiro, C, Robb, M, Marovich, M, Earl, P, Moss, B, Buma, D, Janabi, M, Wahren, B, Mhalu, F, Ferrari, G, Sandstrom, E, and Biberfeld, G. "A Late Third HIV-MVA Vaccination Boosted Strong and Potent Immune Responses in Tanzanian Volunteers Previously Immunized with HIV-DNA and HIV-MVA." November 1, 2013. Link to Item
  - Li, SS, Gilbert, PB, Tomaras, GD, Kijak, G, Ferrari, G, Thomas, R, Zolla-Pazner, S, Evans, DT, Li, Y, Gottardo, R, Dai, JY, Janes, H, Morris, D, Fong, Y, Edlefsen, PT, Li, F, Magaret, CA, Frahm, N, Alpert, MD, Rerks-Ngarm, S, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Robb, ML, O'Connell, RJ, Michael, NL, Kim, JH, McElrath, MJ, and Geraghty, DE. "Association of Fc gamma RIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144." November 1, 2013. Link to Item
  - Pollara, J, Bonsignori, M, Moody, M, Alam, S, Hwang, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Tsao, C, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Tomaras, GD, Kim, JH, Michael, NL, Montefiori, DC, Liao, H, Haynes, BF, Ferrari, G, and Immunology, CHIVAIDSV. "Heterogeneity of Anti-V2 ADCC Ab Responses and Implications for Vaccine Development." November 1, 2013. Link to Item
  - Schifanella, L, Gordon, S, Vaccari, M, Binello, N, Caccuri, F, Blackburn, M, Fenizia, C, Doster, M, Pegu, P, Liynage, N, Shen, X, Tomaras, G, Rao, M, Ferrari, G, Venzon, D, Stablien, D, Barnett, S, Tartaglia, J, and Franchini, G. "MF59 and ALUM, in Combination with an ALVAC-SIV/gp120 Vaccine, Induce Plasmablasts that Differ in the Expression of Homing Markers." November 1, 2013. Link to Item
  - Vaccari, M, Gordon, SN, Doster, M, Liynage, N, Pegu, P, Schifanella, L, Keele, BF, Shen, X, Tomaras, GD, Rao, M, Montefiori, DC, Ferrari, G, Foulds, K, Roederer, M, Venzon, D, Stablein, DM, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, and Franchini, G. "Protection from SIVmac251 Acquisition by an ALVAC/SIV/gp120 Regimen Is Not Improved by the Increase of Anti-Envelope Antibodies and T Cell Responses." November 1, 2013. Link to Item
  - Wise, M, Hutnick, N, Pollara, J, Myles, D, Khan, A, Barnette, S, Ferrari, G, Montefiori, D, Sardesai, N, and Weiner, D. "Multiclade E-DNA Prime Enhances the Functional Antibody Response Induced by a Recombinant gp120 Boost in Non-human Primates." November 1, 2013. Link to Item
  - Bonsignori, M, Pollara, J, Moody, MA, Kepler, TB, Chen, X, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, JH, Michael, NL, Montefiori, DC, Liao, H, Ferrari, G, and Haynes, BF. "Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family." : Springer Nature, September 2012. Full Text
  - Franchini, G, Pegu, P, Gordon, S, Keele, B, Doster, M, Guan, Y, Ferrari, G, Pal, R, Ferrari, MG, Whitney, S, Hudacik, L, Billings, E, Rao, M, Montefiori, D, Venzon, D, Fenizia, C, Lifson, J, Stablein, D, Tartaglia, J, Michael, N, and Kim, J. "Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial." : Springer Nature, September 2012. Full Text
  - Joachim, A, Nilsson, C, Aboud, S, Lyamuya, EF, Robb, M, Marovich, M, Ochsenbauer, C, Wahren, B, Sandström, E, Biberfeld, G, Ferrari, G, and Polonis, VR. "Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults." : Springer Nature, September 2012. Full Text
  - Pollara, J, Bonsignori, M, Moody, M, Alam, M, Liao, H, Hwang, K, Pickeral, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Montefiori, D, Robinson, JE, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Michael, N, Tomaras, G, Haynes, BF, and Ferrari, G. "Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes." : Springer Nature, September 2012. Full Text
  - Williams, WB, Jones, K, Krambrink, A, Grove, D, Liu, P, Yates, NL, Moody, MA, Ferrari, G, Pollara, J, Moodie, Z, Morgan, CA, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, S, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Churchyard, G, Keefer, M, Graham, BS, Haynes, BF, and Tomaras, GD. "Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial." : Springer Nature, September 2012. Full Text
  - Hutnick, NA, Karuppiah, M, Pollara, J, Yan, J, Myles, DJ, Broderick, K, Morrow, M, Sardasai, N, Montefiori, D, Barnett, S, Ferrari, G, and Weiner, DB. "E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost." : Springer Nature, 2012. Full Text
  - Ferrari, G, Cox, J, Garcia, A, Rountree, W, DeCastro, C, Louzao, R, Liebl, B, Sambor, A, Sanchez, A, Sarzotti-Kelsoe, M, Lane, J, D'Souza, P, Koup, R, and Denny, T. "Development of CAVD/EQAPOL Long-Term PBMC Repository ('07-'10) @ DUMC; T-Cell Functionality as Measured by ELISpot and Flow Cytometry Is Maintained Ov." October 2011. Link to Item
  - Ferrari, G, Pollara, J, Kozink, D, Harms, T, Drinker, M, Freel, S, Moody, MA, Tomaras, GD, Ochsenbauer, C, Kappes, JC, Shaw, GM, Hoxie, JA, Robinson, JE, Montefiori, DC, Haynes, BF, and Teams, CHAVICAVD-VIMC. "Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects." October 2011. Link to Item
  - Fouda, G, Yates, N, Pollara, J, Overman, G, Mahlokozera, T, Wilks, A, Kang, H, Ferrari, G, Tomaras, G, Montefiori, D, and Permar, S. "HIV Neutralization in Breast Milk Mirrors that of Plasma and Is Mainly Mediated by IgG Antibodies." October 2011. Link to Item
  - Franchini, G, Pegu, P, Vaccari, M, Gordon, S, Keele, B, Doster, M, Guan, Y, Ferrari, G, Montefiori, D, Venzon, D, Fenizia, C, Lifson, J, Michael, N, Kim, J, and Tartaglia, J. "Titered Mucosal Challenge of Rhesus Macaques with SIVmac251 Recapitulates HIV Vaccine Efficacy in Humans." October 2011. Link to Item
  - Franchini, G, Vaccari, M, Keele, B, Doster, M, Ma, Z, Hryniewicz, A, Morgan, T, Guan, Y, Ferrari, G, Montefiori, D, Venzon, D, Fenizia, C, Lifson, JD, Miller, C, and Tartaglia, J. "Efficacy of HIV Vaccine Candidate in Macaques Dependent on the Dose of SIVmac251 Challenge Exposure: Immune Correlates of Vaccine Efficacy." October 2011. Link to Item
  - Freel, SA, Picking, RA, Ferrari, G, Ochsenbauer, C, Kappes, JC, Kirchherr, J, Weinhold, KJ, Soderberg, K, McMichael, AJ, Haynes, BF, and Tomaras, GD. "Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses." October 2011. Link to Item
  - Pollara, J, Morris, L, Meguid, N, Pickeral, J, Hoxie, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Tomaras, G, Haynes, B, Montefiori, D, Ferrari, G, and Teams, CHAVICAVD-CAVIMC. "Ontogeny, Breadth, and Specificity of Circulating ADCC-Mediating Antibodies in HIV-1 Infected Individuals." October 2011. Link to Item
  - Ferrari, G, Korber, B, Turnbull, E, Liu, MK, Goonetilleke, N, Salazar, J, Betts, M, Gray, CM, Roederer, M, McMichael, A, Weinhold, K, and Team, CHAVI. "High magnitude and multifunctionality epitope-specific CD8+T-cell responses are associated are associated with selection of escape mutants in acute HIV infection." October 2010. Link to Item
  - Pollara, J, Hart, L, Hoxie, J, Kappes, J, Ochsenbauer, C, Morris, L, Soderberg, K, Tomaras, G, Haynes, B, Montefiori, D, Ferrari, G, and Teams, CHAVICAVD-CAVIMC. "High titers of cross-clade ADCC-mediating antibodies are detectable in plasma samples collected from individuals with broadly neutralizing antibodies." October 2010. Link to Item
  - Pollara, J, Landucci, G, Trac, C, White, C, Yates, N, Kappes, J, Ochsenbauer, C, Shaw, G, Hahn, B, Hoxie, J, Liao, H, Cohen, M, Montefiori, D, Soderberg, K, Tomaras, G, Haynes, B, Forthal, D, Ferrari, G, and Team, CHAVI. "Early Appearance of ADCC- and ADCVI-mediating Antibody Responses Against Autologous HIV-1 Transmitted/Founder Virus." October 2010. Link to Item
  - Yates, N, Shen, X, Liu, P, Barnett, S, Spearman, P, Lu, S, Ferrari, G, Alam, M, Overman, R, Lucas, J, Ashley, V, Vaine, M, Wang, S, Liao, H, Hural, J, Weinhold, K, McElrath, J, Haynes, B, Montefiori, D, and Tomaras, G. "Vaccine-Elicited IgG Subclasses and Functional Antibodies." October 2010. Link to Item
  - Freel, SA, Chattopadhyay, PK, Lamoreaux, L, Zarkowsky, D, Overman, RG, Ochsenbauer-Jambor, C, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Koup, RA, Graham, BS, Haynes, BF, Roederer, M, and Tomaras, GD. "S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers." : Springer Nature, October 2009. Full Text
  - Liu, MK, Ferrari, G, Salazar, J, Keele, B, Tanner, RL, Hraber, P, Giorgi, E, Ganusov, VV, Learn, GH, Salazar, MG, Moore, SR, Digleria, K, Yu, Z, Rostron, T, DeBoer, C, Williams, A, Margaret, C, Kopycinski, J, Campion, SL, Bourne, VE, Brackenridge, S, Hahn, B, Cohen, M, Borrow, P, Weinhold, K, Perelson, A, Shaw, G, Korber, BT, Goonetilleke, N, and McMichael, AJ. "OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection." : Springer Nature, October 2009. Full Text
  - Cristillo, AD, Ferrari, G, Hudacik, L, Thompson, D, Bowen, B, Lewis, B, Galmin, L, Suschak, J, Petrovsky, N, Markham, P, and Pal, R. "P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants." January 2009. Full Text
  - Ferrari, G, Garcia-Louzao, A, Cox, J, Sambor, A, D'Souza, P, Gray, C, Jaimes, M, Maecker, H, Levine, G, Koup, R, and Denny, T. "Establishing PBMC Repository for T Cell Assays Optimization and Proficiency Testing in CTC-VIMC Laboratories." October 2008. Link to Item
  - Ferrari, G, Liu, M, Marking, C, Goonetilleke, N, Betts, M, Gray, C, Haynes, B, McMichael, A, and Weinhold, K. "Lack of Highly Poly-Functional Epitope-Specific CD8+Memory T Cell Responses during Spontaneous Control of Viremia." October 2008. Link to Item
  - Liu, MK, Ferrari, G, Salazar, J, Keele, B, Tanner, RL, Turnbull, E, Mlotshwa, M, Treurnicht, F, Hahn, B, Korber, BT, De Boer, C, Williams, A, Gray, C, Williamson, C, Cohen, M, Borrow, P, Weinhold, K, Shaw, G, Goonetilleke, N, McMichael, AJ, and Re, CBUNCD. "T Cell Escape in Subjects with Acute HIV-1 Infection." October 2008. Link to Item
  - Sichangi, MW, Bartlett, J, Ferrari, G, Crump, J, Muisyo, A, Puleo, J, Moody, T, Haynes, B, and Shao, J. "Detection of Cross-Clade T- and B-Cell-Mediated Immune Responses among HIV-1 Infected Individuals in Northern Tanzania." October 2008. Link to Item
  - Lathey, J, Oden, N, Gregory, S, Cox, J, Ferrari, G, Zimmermann, S, Koup, R, Patricia D'Souza, M, and Rodriguez-Chavez, I. "Sa.133. ELISpot Proficiency Testing for International Laboratories Participating in HIV Vaccine Trials." : Elsevier BV, January 2006. Full Text
  - Sempowski, GD, Hicks, C, Edwards, L, Ferrari, G, Eron, J, and Haynes, BF. "Naive T cells are maintained in the periphery during acute HIV infection." : FEDERATION AMER SOC EXP BIOL, March 20, 2002. Link to Item
  - Demarest, JF, Jones, SB, Ferrari, G, Johnson, CJ, Greenberg, M, O'Brien, TO, Blattner, W, Edwards, J, Bartholomew, C, Cleghorn, F, and Weinhold, KJ. "Natural history of HIV-specific CTL activity during acute HIV infection: envelope CTL impact subsequent plasma viremia." March 12, 1999. Link to Item
  - Stranford, S, Skurnick, J, Louria, D, Osmond, D, Chang, S-Y, Sninsky, J, Ferrari, G, Weinhold, K, Lindquist, C, and Levy, J. "The CD8+ cell non-cytotoxic, anti-HIV response is associated with protection in HIV-exposed, uninfected individuals." 1998.
  - Weinhold, KJ, Humphrey, W, Corr, K, Johnson, J, West, M, Wiggins, C, Jones, S, Ottinger, J, Blanks, M, and Ferrari, G. "Cellular immune responses to candidate AIDS vaccines." 1998. Link to Item
  - Laughlin, MJ, Kurtzberg, J, Weinhold, K, Ferrari, G, Pilgrim, A, Gelber, C, Nair, S, Gilboa, E, Smith, CA, Martinek, L, DeOliveira, D, and Lyerly, HK. "Generation of T lymphocyte clones specific for acute lymphoblastic leukemia (ALL) via dendritic cell (DC) presentation." November 15, 1996. Link to Item
  - FERRARI, G, PLACE, C, BARTLETT, J, MOODY, D, TARTAGLIA, J, PAOLETTI, E, and WEINHOLD, K. "ANTIGEN-SPECIFIC ACTIVATION/EXPANSION OF HUMAN ANTI-HIV CTL USING RECOMBINANT ALVAC (CANARYPOX)-BASED VECTORS." April 2, 1995. Link to Item
  - FERRARI, G, KING, K, PACKARD, M, BARTLETT, JA, TARTAGLIA, J, TOSO, J, and WEINHOLD, KJ. "THE EFFECT OF INTERLEUKIN-7 ON FUNCTIONAL AND PHENOTYPIC PROPERTIES OF ANTIGEN-DRIVEN CTL." 1994. Link to Item
  - WEINHOLD, KJ, RATHBUN, KT, PLACE, CA, FERRARI, G, and BOLOGNESI, DP. "CYTOTOXIC T-LYMPHOCYTE REACTIVITIES AMONG HIV-1 VACCINE RECIPIENTS IN THE AIDS VACCINE EVALUATION NETWORK." 1994. Link to Item
  - FERRARI, G, PACKARD, MV, BARTLETT, JA, and WEINHOLD, KJ. "TH1 AND TH2 CD4 SUBSET RESPONSES IN HIV-1 INFECTED INDIVIDUALS AT VARIOUS STAGES OF DISEASE." March 29, 1993. Link to Item
  - WEINHOLD, KJ, FERRARI, G, and ARTHUR, LO. "COMPARISON OF CELLULAR ANTIVIRAL CYTOTOXICITIES PRESENT IN HIV-1 INFECTED HUMANS AND CHIMPANZEES." May 1992. Link to Item
Teaching & Mentoring
Recent Courses
Advising & Mentoring
- I have been involved in teaching and training new researchers in several capacities. Since 2001, as part of consulting work for the World Health Organization and United Nation AIDS program (WHO/UNAIDS), I have organized and taught in 8 international ELISpot and Flow Cytometry workshops in South America (1), Asia (1), and Africa (6) to developing international sites that can perform vaccine clinical trials. In this capacity, I have taught more than 150 young investigators around the world. In 2002 and 2003, I taught the HIV-1 Vaccine development lecture for the IMM291 Comprehensive Immunology Course in the Duke Department of Immunology. Starting in 2007, I have also been awarded two R13 grants from the NIH to organize a series of International Symposia in South Africa that fosters interactions between young African scientists selected among those working in the HIV, TB, and malaria fields and senior international faculty. We have currently provided career development opportunity to more than 52 young investigators and facilitated the forum for a network of young investigators within the African continents.
  Moreover, I was one of the Co-Investigators for the MEPI project directed by Dr. J. Bartlett that collaborates with the Faculty at the Kilimanjaro Christian Medical College to develop a new curriculum of study for the students and to improve the teaching curriculum for the faculty members within the Basic Science fields. I consider this teaching as an integral part of my mandate as a scientist interested in Global Health to promote the education and interaction of the generation of young investigators, with particular focus on the African community.Mentoring has also been an important aspect of my career. Since joining the faculty in 2001, I have mentored 6 undergraduate students during their junior and senior year to perform independent research projects in my laboratory. Of them, 2 have already achieved their medical degree (Dr. Kolappa from John Hopkins University in 2009, Dr. Chaudhry from Brown University in 2009). Ms Hofmair is completing her medical degree at Duke University while achieving a MBA in medical science and a MPH in women health. Mr. Laithi graduated in 2010 and applying to Medical School for 2012. Ms. DiMarco who has recently graduated in May 2012 and has been accepted in Medical School at he University of Virginia. Mr. Hickey has completed his junior year project and we rejoin the lab after a summer internship at the University of KwaZulu-Natal (Durban, South Africa).
  
  In 2006, Marc Frahm joined my laboratory as graduate students for the Molecular Genetics and Microbiology Department. He has currently achieved the necessary requirements to defend his thesis and will graduate in August 2012.
  
  I have been a faculty mentor for the AIDS Training Grant starting in 2005 (Department of Medicine, T32). I have directly mentored two post-doctoral fellows Dr. Jie Yu (2007-2010) and Dr, Justin Pollara (2010-currently). Dr Yu is currently a Research Associate at Duke University with Dr. Chen after completing 3 years of training in my laboratory. Dr. Pollara is still in my laboratory and has already published 19 manuscripts, of which four as first author, and has five more manuscripts in preparation, two of those as first author. Dr. Pollara has been awarded a CHAVI Young Investigator for his work on fundamental insights into the HIV-1 ADCC antibody response. My career goals since joining the Duke faculty in September 2001 have been to make an impact on young investigators through basic research and teaching and mentoring undergraduate, graduate and medical students, and postdoctoral fellows at Duke University.
Available to mentor:
- PhD
- Post-Doc
- Undergraduate
Scholarly, Clinical, & Service Activities
Presentations & Appearances

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Academic Positions Outside Duke

In the News

Subject Headings

Global Scholarship

Research

Selected Grants

Selected Publications

Academic Articles

Book Sections

Other Articles

Conference Papers

Recent Courses

Advising & Mentoring

Available to mentor:

Presentations & Appearances